{
  "meta": {
    "title": "Late_Night_Pyq_Obg-1",
    "url": "https://brainandscalpel.vercel.app/late-night-pyq-obg-1-c6907d3d.html",
    "scrapedAt": "2025-11-29T18:10:24.739Z"
  },
  "questions": [
    {
      "id": 5897,
      "choices": [
        {
          "id": 23558,
          "text": "<p><span style=\"font-size:12pt;\">106 mg/dL</span></p>"
        },
        {
          "id": 23559,
          "text": "<p><span style=\"font-size:12pt;\">126 mg/dL</span></p>"
        },
        {
          "id": 23560,
          "text": "<p><span style=\"font-size:12pt;\">116 mg/dL</span></p>"
        },
        {
          "id": 23561,
          "text": "<p><span style=\"font-size:12pt;\">130 mg/dL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You discover that there is evidence of cardiac malformation in a fetus during a routine US scan at 16 weeks. What is the minimum level of fasting blood sugar at which you can suspect overt diabetes?&nbsp;</span>(NEET PG 2019)</p>",
      "unique_key": "Q8189139",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589596,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 126 mg/dL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Overt diabetes in a patient is diagnosed based on specific blood glucose levels. The criteria for diagnosing overt diabetes are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Fasting blood sugar:</strong> ≥ 126 mg/dL</span></li><li><span style=\"font-size:12pt;\"><strong>Random blood sugar:</strong> ≥ 200 mg/dL</span></li><li><span style=\"font-size:12pt;\"><strong>HbA1c:</strong> ≥ 6.5%</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">During pregnancy, maternal hyperglycemia, especially during the first trimester when organogenesis occurs, increases the risk of fetal congenital malformations, including cardiac malformations. This is particularly true for women with pre-gestational diabetes, not gestational diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 106 mg/dL</strong>: This is incorrect. A fasting blood sugar level of 106 mg/dL does not meet the threshold for diagnosing overt diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 116 mg/dL</strong>: This is incorrect. A fasting blood sugar level of 116 mg/dL is higher than normal but still below the threshold for diagnosing overt diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 130 mg/dL</strong>: This is incorrect. Although higher than the threshold, the minimum level to suspect overt diabetes is 126 mg/dL, not 130 mg/dL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Overt diabetes in pregnancy is diagnosed with a fasting blood sugar level of ≥ 126 mg/dL, and maternal hyperglycemia.</span></p>",
      "correct_choice_id": 23559,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5953,
      "choices": [
        {
          "id": 23782,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop warfarin and start LMWH.</span></span></span></p>"
        },
        {
          "id": 23783,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop warfarin and start heparin.</span></span></span></p>"
        },
        {
          "id": 23784,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue warfarin.</span></span></span></p>"
        },
        {
          "id": 23785,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop warfarin, start LMWH and aspirin.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant woman at 36 weeks of gestation with a prosthetic valve replacement for mitral stenosis is on warfarin therapy 4mg/ day. What is the appropriate next step in management.</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-size:14px\">(NEET PG 2021)</span></span></span></span></p>",
      "unique_key": "Q9123051",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589311,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Stop warfarin and start LMWH.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop warfarin and start LMWH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Warfarin is teratogenic and has a significant risk of causing warfarin embryopathy, particularly in doses greater than 5mg per day. In pregnancy, it is recommended to change warfarin to low molecular weight heparin (LMWH) or unfractionated heparin (UFH) in the first trimester, especially if the warfarin dose exceeds 5 mg/day. After 13 weeks, it can be switched back to warfarin until delivery. Near delivery, warfarin should again be replaced by LMWH or UFH to manage the risk of bleeding complications during delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Stop warfarin and start heparin:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option is partially correct as it aligns with the practice of switching from warfarin to a safer anticoagulant near delivery. However, the preferred anticoagulant in this situation is LMWH due to its predictable pharmacokinetics and ease of administration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Continue warfarin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is incorrect because continuing warfarin at 36 weeks of gestation poses significant risks of fetal hemorrhage and warfarin embryopathy. It is essential to switch to a safer anticoagulant like LMWH or UFH close to delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Stop warfarin, start LMWH and aspirin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While this option includes stopping warfarin and starting LMWH, which is correct, the addition of aspirin is only indicated in women who are at a very high risk of thrombosis. The general recommendation does not include aspirin unless there is a specific high-risk indication.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Warfarin should be replaced by low molecular weight heparin (LMWH) or unfractionated heparin (UFH) near delivery to manage the risks associated with its teratogenic effects and potential complications during delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 2404, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23782,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5867,
      "choices": [
        {
          "id": 23438,
          "text": "<p><span style=\"font-size:12pt;\">Pre-gestational diabetes</span></p>"
        },
        {
          "id": 23439,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Gestational diabetes mellitus</span></p>"
        },
        {
          "id": 23440,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Effect of valproate</span></p>"
        },
        {
          "id": 23441,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Hypertensive on ACE inhibitors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the maternal condition that can lead to the findings in the baby as shown below?&nbsp;</span>(NEET PG 2020)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/picture5.jpg\" alt=\"\" width=\"300\" height=\"318\"></span></p>",
      "unique_key": "Q8694615",
      "question_audio": null,
      "question_video": null,
      "map_id": 37489401,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Pre-gestational diabetes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The image shows a condition known as mermaid syndrome or sirenomelia, which is a rare congenital deformity characterized by the fusion of the lower limbs. This condition is characteristically associated with overt (pre-gestational) diabetes mellitus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Sirenomelia (mermaid syndrome) is strongly linked to maternal pre-gestational diabetes.</span></li><li><span style=\"font-size:12pt;\">Overt diabetes mellitus during pregnancy is known to cause various congenital anomalies, with cardiac anomalies being the most common, specifically ventricular septal defects (VSD).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Gestational diabetes mellitus:</strong> Gestational diabetes typically occurs later in pregnancy and does not usually cause congenital anomalies, as organogenesis is largely complete by the time gestational diabetes is diagnosed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Effect of valproate:</strong> Valproate exposure during pregnancy is associated with neural tube defects, facial anomalies (such as cleft lip and palate), and cardiac anomalies, but not sirenomelia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Hypertensive on ACE inhibitors:</strong> ACE inhibitors and angiotensin receptor blockers reduce fetal renal perfusion, leading to conditions such as oligohydramnios and subsequent pulmonary hypoplasia, but they do not cause sirenomelia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Pre-gestational diabetes is associated with an increased risk of congenital anomalies, including mermaid syndrome (sirenomelia), characterized by the fusion of lower limbs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 384, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23438,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5740,
      "choices": [
        {
          "id": 22932,
          "text": "<p><span style=\"font-size:12.0pt;\">Development of cardiac failure within 5 months of delivery</span></p>"
        },
        {
          "id": 22933,
          "text": "<p><span style=\"font-size:12.0pt;\">Left ventricular diastolic dysfunction</span></p>"
        },
        {
          "id": 22934,
          "text": "<p><span style=\"font-size:12.0pt;\">Absence of identifiable cause</span></p>"
        },
        {
          "id": 22935,
          "text": "<p><span style=\"font-size:12.0pt;\">Dilated left ventricle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All are true regarding peripartum cardiomyopathy except?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q6685117",
      "question_audio": null,
      "question_video": null,
      "map_id": 37489349,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Left ventricular diastolic dysfunction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Peripartum cardiomyopathy (PPCM) is a form of heart failure<strong> that occurs during the last month of pregnancy or within five months postpartum</strong>. It is characterized by left ventricular systolic dysfunction, rather than diastolic dysfunction. The diagnostic criteria for PPCM include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Cardiac failure developing in the last month of pregnancy or within five months after delivery.</span></li><li><span style=\"font-size:12.0pt;\">Absence of an identifiable cause for the cardiac failure.</span></li><li><span style=\"font-size:12.0pt;\">Absence of recognizable heart disease prior to the last month of pregnancy.</span></li><li><span style=\"font-size:12.0pt;\">Echocardiographic evidence of left ventricular systolic dysfunction (ejection fraction &lt;45% or fractional shortening &lt;30%) along with a dilated left ventricle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Development of cardiac failure within 5 months of delivery</strong>: Correct. PPCM develops within five months of delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Absence of identifiable cause</strong>: Correct. PPCM is diagnosed in the absence of an identifiable cause for cardiac failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Dilated left ventricle</strong>: Correct. PPCM is associated with a dilated left ventricle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Peripartum cardiomyopathy is characterized by left ventricular systolic dysfunction and occurs within the last month of pregnancy or up to five months postpartum, in the absence of an identifiable cause for cardiac failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: https://www.ncbi.nlm.nih.gov/books/NBK482185/</strong></span></p>",
      "correct_choice_id": 22933,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5923,
      "choices": [
        {
          "id": 23662,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt;92 mg/dL</span></p>"
        },
        {
          "id": 23663,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt;95 mg/dL</span></p>"
        },
        {
          "id": 23664,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt;106 mg/dL</span></p>"
        },
        {
          "id": 23665,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt;90 mg/dL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">According to IADPSG, what is the cut-off value of fasting blood glucose for the diagnosis of gestational diabetes mellitus?&nbsp;</span>(INICET MAY 2021)</p>",
      "unique_key": "Q2873248",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589772,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) &gt; 92 mg/dL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The International Association of Diabetes and Pregnancy Study Groups (IADPSG) has established criteria for the diagnosis of gestational diabetes mellitus (GDM). According to their guidelines:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The fasting blood glucose cut-off value for diagnosing GDM during a 75g oral glucose tolerance test (OGTT) is <strong>&gt;92 mg/dL</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This value is used as part of a comprehensive assessment, including 1-hour and 2-hour postprandial glucose levels. The IADPSG criteria for GDM diagnosis include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Fasting:</strong> ≥92 mg/dL</span></li><li><span style=\"font-size:12.0pt;\"><strong>1-hour:</strong> ≥180 mg/dL</span></li><li><span style=\"font-size:12.0pt;\"><strong>2-hour:</strong> ≥153 mg/dL</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If any one of these values is abnormal, the diagnosis of GDM can be made.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. &gt;95 mg/dL</strong>: This is not the IADPSG recommended cut-off for fasting blood glucose. It is higher than the specified cut-off value for diagnosing GDM.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. &gt;106 mg/dL</strong>: This value is significantly higher than the recommended cut-off. It exceeds the threshold for diagnosing GDM according to IADPSG guidelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. &gt;90 mg/dL</strong>: While this value is close, it is slightly below the IADPSG recommended cut-off of &gt;92 mg/dL for diagnosing GDM.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cut-off value of fasting blood glucose for the diagnosis of gestational diabetes mellitus according to IADPSG is &gt;92 mg/dL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 326, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23662,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5967,
      "choices": [
        {
          "id": 23838,
          "text": "<p><span style=\"font-size:12pt;\">Syphilis</span></p>"
        },
        {
          "id": 23839,
          "text": "<p><span style=\"font-size:12pt;\">Antiphospholipid antibody syndrome</span></p>"
        },
        {
          "id": 23840,
          "text": "<p><span style=\"font-size:12pt;\">TORCH infections</span></p>"
        },
        {
          "id": 23841,
          "text": "<p><span style=\"font-size:12pt;\">Gestational diabetes mellitus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old G4A3 woman had a history of miscarriage at 8 weeks, the second miscarriage at 11 weeks with no cardiac activity, and the third pregnancy loss at 24 weeks with preterm delivery due to early-onset preeclampsia. What is the most probable diagnosis? (NEET PG 2021)</span></p>",
      "unique_key": "Q4374771",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589310,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Antiphospholipid antibody syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Antiphospholipid antibody syndrome:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The patient's history of recurrent pregnancy loss (RPL) and a pregnancy complicated by early-onset preeclampsia is highly suggestive of Antiphospholipid Antibody Syndrome (APLA).</span></li><li><span style=\"font-size:12pt;\">APLA is diagnosed based on clinical and laboratory criteria. The clinical criteria include obstetric complications such as unexplained fetal death, severe preeclampsia necessitating early delivery, and recurrent early pregnancy losses. Vascular thrombosis is also a clinical criterion.</span></li><li><span style=\"font-size:12pt;\">Laboratory criteria include the presence of lupus anticoagulant, medium to high titers of anticardiolipin antibodies, and anti-β2 glycoprotein antibodies. These must be present on two or more occasions at least 12 weeks apart.</span></li><li><span style=\"font-size:12pt;\">The Sapporo Criteria for diagnosing APLA require at least one clinical and one laboratory criterion to be present.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Syphilis:</strong> Although syphilis can cause adverse pregnancy outcomes, including miscarriage and stillbirth, it is less likely than APLA to cause the combination of early pregnancy loss and early-onset preeclampsia described in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. TORCH infections:&nbsp;</strong>TORCH infections (Toxoplasmosis, Other agents, Rubella, Cytomegalovirus, and Herpes simplex virus) can lead to congenital anomalies, intrauterine growth restriction, and pregnancy loss. However, recurrent pregnancy loss due to TORCH infections is rare.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Gestational diabetes mellitus:&nbsp;</strong>Gestational diabetes mellitus (GDM) typically affects pregnancies later in gestation and is associated with macrosomia, neonatal hypoglycemia, and other complications, but it is not commonly associated with recurrent pregnancy loss or early-onset preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Antiphospholipid antibody syndrome is characterized by recurrent pregnancy loss and complications such as early-onset preeclampsia, necessitating early delivery. Diagnosis is based on the presence of clinical and laboratory criteria according to the Sapporo Criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2550, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23839,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/5967/Neet_Pg_2021_Obg_Q_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/5967/Neet_Pg_2021_Obg_Q_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55314,
      "choices": [
        {
          "id": 220717,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Preeclampsia</span></span></span></p>"
        },
        {
          "id": 220718,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gestational HTN</span></span></span></p>"
        },
        {
          "id": 220719,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic HTN</span></span></span></p>"
        },
        {
          "id": 220720,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic HTN with superimposed preeclampsia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A G2P1 at 17 weeks presented to the OPD with a BP of 148/90 mmHg. Six hours later, her BP is 142/90 mmHg. What is the diagnosis? (FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q8002845",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589860,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>C) Chronic HTN</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In pregnancy, the timing of hypertension onset is critical in determining the diagnosis. Chronic hypertension is defined as high blood pressure that is present before pregnancy or that is diagnosed before 20 weeks of gestation. This patient&#39;s blood pressure readings of 148/90 mmHg and 142/90 mmHg at 17 weeks of gestation indicate hypertension occurring before the 20-week threshold, fitting the definition of chronic hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To confirm chronic hypertension, if the patient&#39;s blood pressure remains elevated 12 weeks postpartum, the diagnosis is solidified.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Preeclampsia:</strong> This is incorrect because preeclampsia is characterized by hypertension that develops after 20 weeks of gestation and is accompanied by proteinuria. This patient&#39;s hypertension was noted before 20 weeks and there is no mention of proteinuria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Gestational HTN:</strong> This option is incorrect as gestational hypertension also develops after 20 weeks of gestation. This patient&#39;s hypertension was detected at 17 weeks, making this diagnosis unlikely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Chronic HTN with superimposed preeclampsia:</strong> This is incorrect because superimposed preeclampsia would require evidence of new-onset proteinuria or worsening hypertension after 20 weeks of gestation in a patient with pre-existing chronic hypertension. There is no mention of proteinuria in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypertension diagnosed before 20 weeks of gestation in a pregnant woman is most likely chronic hypertension.</span></span></span></p>",
      "correct_choice_id": 220719,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5941,
      "choices": [
        {
          "id": 23734,
          "text": "<p><span style=\"font-size:12pt;\">Prevention of seizures in severe pre-eclampsia</span></p>"
        },
        {
          "id": 23735,
          "text": "<p><span style=\"font-size:12pt;\">Prevention of recurrent seizures in eclampsia</span></p>"
        },
        {
          "id": 23736,
          "text": "<p><span style=\"font-size:12pt;\">Prevention of RDS in premature baby</span></p>"
        },
        {
          "id": 23737,
          "text": "<p><span style=\"font-size:12pt;\">Reducing contractility of uterus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Magnesium sulphate has no role in? (NEET PG 2019)</span></p>",
      "unique_key": "Q2178849",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589594,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Prevention of RDS in premature baby</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Magnesium Sulphate (MgSO4):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">MgSO4 is used for several obstetric indications, including:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Eclampsia:</strong> MgSO4 is the drug of choice for the prevention and treatment of seizures in eclampsia.</span></li><li><span style=\"font-size:12pt;\"><strong>Prevention of Seizures in Severe Pre-eclampsia:</strong> It is used prophylactically to prevent seizures in women with severe pre-eclampsia.</span></li><li><span style=\"font-size:12pt;\"><strong>Tocolytic in Preterm Labor:</strong> MgSO4 is used as a tocolytic agent to reduce uterine contractions and delay preterm labor.</span></li><li><span style=\"font-size:12pt;\"><strong>Neuroprotection in Severe Preterm Infants (&lt;29 weeks):</strong> MgSO4 is administered to provide neuroprotection for the fetus, reducing the risk of cerebral palsy and other neurological disorders in preterm infants.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Prevention of RDS (Respiratory Distress Syndrome) in Premature Baby:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">MgSO4 does not play a role in the prevention of RDS. Instead, corticosteroids (such as betamethasone or dexamethasone) are used to accelerate fetal lung maturation and reduce the risk of RDS in preterm babies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Prevention of Seizures in Severe Pre-eclampsia:</strong> MgSO4 is effectively used to prevent seizures in women with severe pre-eclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Prevention of Recurrent Seizures in Eclampsia:</strong> MgSO4 is the preferred treatment to prevent recurrent seizures in women with eclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Reducing Contractility of Uterus:</strong> MgSO4 is used as a tocolytic agent to reduce uterine contractility and delay preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Corticosteroids are used for the prevention of respiratory distress syndrome in preterm babies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 1860, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23736,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55339,
      "choices": [
        {
          "id": 220817,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Domperidone</span></span></span></p>"
        },
        {
          "id": 220818,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased fluid intake</span></span></span></p>"
        },
        {
          "id": 220819,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Small frequent meals</span></span></span></p>"
        },
        {
          "id": 220820,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MTP</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vomiting in pregnancy is managed by? (FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q2963480",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589858,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Small frequent meals</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vomiting in pregnancy, often referred to as morning sickness, can be managed by recommending small, frequent meals. This approach helps to stabilize blood sugar levels and reduces the likelihood of nausea. Eating small amounts of food more frequently can prevent the stomach from becoming too full or too empty, both of which can trigger nausea and vomiting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">DOC &ndash; D</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">oxylamine combined with&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">P</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">yridoxine&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">(B6)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Domperidone</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: While domperidone is used for nausea and vomiting, it is not the drug of choice for managing vomiting in pregnancy. The preferred pharmacological treatment is a combination of doxylamine and pyridoxine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Increased fluid intake</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: While staying hydrated is important, increasing fluid intake alone is not the primary management strategy for vomiting in pregnancy. It may be difficult for pregnant women experiencing severe nausea to tolerate large amounts of fluids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. MTP (Medical Termination of Pregnancy)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is not a management option for vomiting in pregnancy. MTP is a procedure for terminating a pregnancy and is unrelated to managing nausea and vomiting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Managing vomiting in pregnancy is best achieved by advising small, frequent meals to help stabilize blood sugar levels and reduce nausea.</span></span></span></p>",
      "correct_choice_id": 220819,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6050,
      "choices": [
        {
          "id": 24170,
          "text": "<p><span style=\"font-size:12pt;\">Acute fatty liver of pregnancy</span></p>"
        },
        {
          "id": 24171,
          "text": "<p><span style=\"font-size:12pt;\">Viral hepatitis</span></p>"
        },
        {
          "id": 24172,
          "text": "<p><span style=\"font-size:12pt;\">Intrahepatic cholestasis</span></p>"
        },
        {
          "id": 24173,
          "text": "<p><span style=\"font-size:12pt;\">HELLP syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant lady with 34 weeks of amenorrhea has the following findings: LDH - 700 IU/L, platelets - 75,000/ mm3, serum bilirubin - 1.5 mg/dL, SGOT - 200 U/L, SGPT - 150 U/L, and BP - 140/96 mm Hg. Her coagulation profile and renal function tests are normal. What is the diagnosis?&nbsp;</span><span style=\"font-size:11pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q3616622",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589306,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) HELLP syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>HELLP Syndrome:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The given clinical scenario with elevated liver enzymes (SGOT and SGPT), elevated bilirubin, low platelet count, and hypertension is indicative of HELLP syndrome.</span></li><li><span style=\"font-size:12pt;\">HELLP is an acronym for:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>H</strong>emolysis (H): Evidence of hemolysis can include elevated LDH.</span></li><li><span style=\"font-size:12pt;\"><strong>E</strong>levated <strong>L</strong>iver enzymes (EL): Both SGOT and SGPT are elevated.</span></li><li><span style=\"font-size:12pt;\"><strong>L</strong>ow <strong>P</strong>latelet count (LP): Platelet count is significantly reduced (below 100,000/mm³).</span></li></ul></li><li><span style=\"font-size:12pt;\">This syndrome is a severe form of preeclampsia and requires immediate medical attention.</span></li><li><span style=\"font-size:12pt;\">Management often involves the termination of pregnancy, with steroid cover for fetal lung maturity and magnesium sulfate (MgSO4) for seizure prophylaxis and neuroprotection of the neonate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Acute Fatty Liver of Pregnancy:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This condition typically occurs during the late second and third trimesters.</span></li><li><span style=\"font-size:12pt;\">Diagnosis is based on the Swansea Criteria, requiring 6 or more specific findings, which often include renal impairment, liver impairment, hypoglycemia, and coagulation defects.</span></li><li><span style=\"font-size:12pt;\">Liver biopsy would show microvascular steatosis.</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Viral Hepatitis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Viral hepatitis can occur at any gestational age and presents with jaundice.</span></li><li><span style=\"font-size:12pt;\">It typically involves markedly elevated bilirubin and significantly raised SGOT and SGPT levels.</span></li><li><span style=\"font-size:12pt;\">This scenario lacks the characteristic very high bilirubin levels seen in viral hepatitis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Intrahepatic Cholestasis of Pregnancy:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Usually occurs in the third trimester and presents with pruritus.</span></li><li><span style=\"font-size:12pt;\">Lab findings typically show mildly elevated bilirubin, elevated SGOT and SGPT, and characteristically raised serum bile acids.</span></li><li><span style=\"font-size:12pt;\">Renal impairment, high BP, and coagulation abnormalities are not seen in intrahepatic cholestasis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">HELLP syndrome is characterized by hemolysis, elevated liver enzymes, and low platelet count. It is a severe form of preeclampsia and necessitates urgent medical intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 1809, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24173,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6050/Neet_Pg_2022_Obg_Q_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6050/Neet_Pg_2022_Obg_Q_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47303,
      "choices": [
        {
          "id": 188823,
          "text": "<p><span style=\"font-size:12.0pt;\">24-28 weeks</span></p>"
        },
        {
          "id": 188824,
          "text": "<p><span style=\"font-size:12.0pt;\">First visit</span></p>"
        },
        {
          "id": 188825,
          "text": "<p><span style=\"font-size:12.0pt;\">32 weeks</span></p>"
        },
        {
          "id": 188826,
          "text": "<p><span style=\"font-size:12.0pt;\">34 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32 weeks pregnant woman is at risk of GDM. She would have likely had a screening test during which time of pregnancy? (FMGE JULY 2023)</span></p>",
      "unique_key": "Q1978895",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589861,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 24-28 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gestational diabetes mellitus (GDM) is typically diagnosed during pregnancy and is due to the hormonal changes associated with pregnancy. These hormonal changes, particularly the placental hormones, cause increased insulin resistance, which generally becomes apparent after 24 weeks of gestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The optimal time to screen for GDM is <strong>between 24 and 28 weeks of pregnancy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This period is chosen because it is when the effects of placental hormones on glucose metabolism become significant enough to detect any abnormalities in glucose tolerance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Screening Methods:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>IADPSG Criteria (International Association of Diabetes and Pregnancy Study Groups)</strong>:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">A 75-gram oral glucose tolerance test (OGTT) is performed.</span></li><li><span style=\"font-size:12.0pt;\">Blood glucose levels are checked fasting, at 1 hour, and at 2 hours after glucose intake.</span></li><li><span style=\"font-size:12.0pt;\">Diagnostic criteria:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Fasting glucose ≥ 92 mg/dL</span></li><li><span style=\"font-size:12.0pt;\">1-hour glucose ≥ 180 mg/dL</span></li><li><span style=\"font-size:12.0pt;\">2-hour glucose ≥ 153 mg/dL</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Any one of these values being abnormal is diagnostic of GDM.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>DIPSI Criteria (Diabetes in Pregnancy Study Group India)</strong>:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The patient does not need to be fasting.</span></li><li><span style=\"font-size:12.0pt;\">A 75-gram glucose load is given, and blood glucose is checked after 2 hours.</span></li><li><span style=\"font-size:12.0pt;\">A value ≥ 140 mg/dL is diagnostic of GDM.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note - First visit</strong> is the time to screen for pre-existing diabetes or overt diabetes in women who may not know they are diabetic. It is not the typical time for GDM screening, which occurs later in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The appropriate time to screen for gestational diabetes mellitus is between 24 and 28 weeks of pregnancy, as this is when the impact of placental hormones on glucose metabolism is most apparent.</span></p>",
      "correct_choice_id": 188823,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/47303/FMGE_July_-_2023OBG_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/47303/FMGE_July_-_2023OBG_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5801,
      "choices": [
        {
          "id": 23175,
          "text": "<p><span style=\"font-size:12pt;\">A and B</span></p>"
        },
        {
          "id": 23176,
          "text": "<p><span style=\"font-size:12pt;\">B and C</span></p>"
        },
        {
          "id": 23177,
          "text": "<p><span style=\"font-size:12pt;\">A, B and C</span></p>"
        },
        {
          "id": 23178,
          "text": "<p><span style=\"font-size:12pt;\">Only C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following statements is true regarding the instrument shown below?&nbsp;</span>(INICET MAY 2018)</p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12pt;\">﻿﻿﻿It is used in women not on thromboprophylaxis and planned for caesarean section.</span></li><li><span style=\"font-size:12pt;\">﻿﻿﻿It is used in women on thromboprophylaxis and planned for caesarean section.</span></li><li><span style=\"font-size:12pt;\">﻿﻿﻿It is removed once the patient starts ambulating.</span></li></ol><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_xyXdk3I.jpg\" alt=\"\" width=\"300\" height=\"258\"></span></p>",
      "unique_key": "Q7044685",
      "question_audio": null,
      "question_video": null,
      "map_id": 37489350,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) A, B and C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The image shows a pneumatic compression hose. It is used in women who are not on any thromboprophylaxis and planned for caesarean section.</span></li><li><span style=\"font-size:12pt;\"><strong>It is also used along with pharmacotherapy in women at risk of thromboembolism undergoing a cesarean section</strong></span></li><li><span style=\"font-size:12pt;\">It is discontinued once the patient starts ambulating post-surgery.</span></li><li><span style=\"font-size:12pt;\">It is used because pregnancy and surgery increase the risk of thromboembolism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Different guidelines are there for different societies (Both ACOG and SMFM) recommend pneumatic compression devices for all patients undergoing cesarean section. This table is from Williams and shows the different guidelines:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-153951.jpg\" alt=\"\" width=\"1000\" height=\"672\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Pneumatic compression devices are used for thromboembolism prevention in women undergoing cesarean sections, whether or not they are on thromboprophylaxis, and are discontinued once the patient starts ambulating post-surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 2575, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23177,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55324,
      "choices": [
        {
          "id": 220757,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Iron prophylaxis is given for 6 months antepartum and 6 months postpartum</span></span></span></p>"
        },
        {
          "id": 220758,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Iron prophylaxis is started at 14 weeks and continued for 6 weeks after delivery</span></span></span></p>"
        },
        {
          "id": 220759,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Iron prophylaxis starts in the 1st trimester and continues till 6 weeks postpartum</span></span></span></p>"
        },
        {
          "id": 220760,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Iron prophylaxis is given 6 months antepartum and 3 months postpartum</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">As per Anemia Mukt Bharat, which is the correct statement regarding iron prophylaxis in pregnant women? (FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q8751917",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589859,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Iron prophylaxis is given for 6 months antepartum and 6 months postpartum</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Anemia Mukt Bharat (AMB) initiative outlines that iron prophylaxis for pregnant women should start from the 14th week of pregnancy and continue throughout the pregnancy (approximately 6 months) and for 6 months postpartum. The recommended dosage is one red-colored, sugar-coated tablet containing 60 mg of elemental iron and 0.5 mg of folic acid daily. This regimen helps in preventing iron deficiency anemia and folate deficiency anemia during and after pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Iron prophylaxis for pregnant women under the Anemia Mukt Bharat initiative is given from 14 weeks of pregnancy and continues for 6 months postpartum.</span></span></span></p>",
      "correct_choice_id": 220757,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5922,
      "choices": [
        {
          "id": 23658,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational diabetes</span></span></span></p>"
        },
        {
          "id": 23659,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Rubella</span></span></span></p>"
        },
        {
          "id": 23660,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Hypothyroidism</span></span></span></p>"
        },
        {
          "id": 23661,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Gestational hypertension</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A baby was born at 34 weeks of pregnancy; the appearance of the baby is given below. What is the mother suffering from?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;</span></span></span>(NEET PG 2019)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/picture7.jpg\" style=\"height:212px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q9932158",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589595,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Gestational diabetes </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shows a large for gestational age (LGA) fetus. Macrosomia is a condition where a newborn baby is significantly larger than average. This can often be identified by a higher birth weight and size compared to typical babies born at the same gestational age.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Causes of Macrosomia:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational Diabetes Mellitus (GDM) and Overt Diabetes Mellitus:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal hyperglycemia leads to fetal hyperglycemia, which stimulates insulin production in the fetus. Insulin acts as a growth hormone, leading to increased fetal growth and fat deposition.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal Obesity:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased maternal body mass index (BMI) is associated with a higher risk of delivering a macrosomic baby.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Previous Baby with Macrosomia:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A history of delivering a large baby increases the risk of subsequent babies also being large.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-term Pregnancy:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pregnancy extending beyond the due date increases the chance of the baby growing larger.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Excessive Weight Gain in Pregnancy:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Significant maternal weight gain during pregnancy contributes to larger fetal size.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conditions Not Associated with Macrosomia:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia and Antepartum Hemorrhage (APH):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These conditions are typically associated with fetal growth restriction rather than macrosomia.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thrombocytopenia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This condition has no direct association with fetal weight.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Rubella:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Rubella infection during pregnancy can cause congenital rubella syndrome, which is typically associated with intrauterine growth restriction (IUGR), not macrosomia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hypothyroidism:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Maternal hypothyroidism can lead to complications such as preterm birth and low birth weight but is not directly linked to macrosomia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Gestational Hypertension:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Gestational hypertension is associated with IUGR and preterm birth rather than increased fetal size.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational diabetes is a significant risk factor for macrosomia, leading to the birth of large for gestational age (LGA) babies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 2169, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23658,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5664,
      "choices": [
        {
          "id": 22628,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start ART immediately and continue till 6 weeks after delivery</span></span></span></span></p>"
        },
        {
          "id": 22629,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start ART after 1st trimester and continue life-long</span></span></span></span></p>"
        },
        {
          "id": 22630,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start ART immediately and continue life-long</span></span></span></span></p>"
        },
        {
          "id": 22631,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start ART after 1st trimester and continue till 6 weeks after delivery</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman is diagnosed to be positive for HIV in her first trimester. What is the most appropriate management?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
      "unique_key": "Q1605584",
      "question_audio": null,
      "question_video": null,
      "map_id": 37489346,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Start ART immediately and continue life long </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The National AIDS Control Organisation (NACO) recommends that all pregnant women with HIV should start antiretroviral therapy (ART) immediately, regardless of the stage of their disease or their CD4 count. This approach is aimed at reducing the viral load as quickly as possible, thereby decreasing the risk of mother-to-child transmission of HIV. ART should be continued lifelong to ensure ongoing viral suppression and the health of the mother.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management of HIV-positive pregnancy includes:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antenatal care:</span></span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testing for other sexually transmitted diseases (STDs), CMV, toxoplasmosis, tuberculosis, fungal, and other opportunistic infections.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partner/husband should also be tested.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To prevent pneumocystis pneumonia, start co-trimoxazole if CD4 count is &le; 250 cells/mm&sup3; and continue through pregnancy, delivery, and breastfeeding (dose: double strength tablet, 1 tablet daily).</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assess immunization status and update as needed.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Counseling on the impact of HIV on pregnancy and factors influencing the progression of the disease and risk of perinatal transmission.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD4 count testing in each trimester.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monitor HIV RNA levels monthly after changing/initiating therapy.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CBC, LFT, and KFT in each trimester.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-retroviral therapy for all:</span></span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As per NACO: Start ART at diagnosis (regardless of CD4 count); continue lifelong.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Initiate lifelong ART in all pregnant women with confirmed HIV infection regardless of WHO clinical stage or CD4 cell count.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TDF + 3TC + EFV is recommended as first-line ART in pregnant and breastfeeding women (including pregnant women in the first trimester of pregnancy).</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pregnant women detected to be HIV-positive for the first time in labor should be initiated on ART (TDF + 3TC + EFV) immediately.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start ART immediately upon diagnosis of HIV in pregnancy and continue lifelong to reduce the risk of mother-to-child transmission and maintain the health of the mother.</span></span></span></span></p>",
      "correct_choice_id": 22630,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5876,
      "choices": [
        {
          "id": 23474,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6 to 10 weeks</span></span></span></p>"
        },
        {
          "id": 23475,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">8 to 12 weeks</span></span></span></p>"
        },
        {
          "id": 23476,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">13 to 20 weeks</span></span></span></p>"
        },
        {
          "id": 23477,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">20 to 28 weeks</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The risk of fetal varicella syndrome is maximum when the mother is infected between:&nbsp;</span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q1066006",
      "question_audio": null,
      "question_video": null,
      "map_id": 37594070,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 13 to 20 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Varicella Zoster Virus (VZV) is a double-stranded DNA virus that is primarily acquired in childhood and causes chickenpox. The virus is transmitted through direct contact with an infected individual. Nonimmune pregnant women who come into close contact with a patient with chickenpox are at risk of contracting the infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If a pregnant woman contracts chickenpox, particularly early in pregnancy, there is a risk of congenital varicella syndrome in the fetus. The highest risk period for the development of congenital varicella syndrome is between 13 and 20 weeks of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital varicella syndrome includes the following features:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chorioretinitis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microphthalmia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cerebral cortical atrophy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal growth restriction</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydronephrosis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Limb hypoplasia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cicatricial skin lesions</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the fetus or neonate is exposed to active VZV infection just before or during delivery (less than 5 days before and up to 2 days after delivery), there is a significant risk of disseminated disease and CNS involvement in the neonate, with a mortality rate of approximately 30%. In such cases, administration of VZIG (Varicella-Zoster Immune Globulin) is recommended.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The highest risk period for the development of congenital varicella syndrome in a fetus is when the mother is infected with Varicella Zoster Virus between 13 and 20 weeks of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 26<sup>th</sup> edition pg 3085</span></strong></span></span></p>",
      "correct_choice_id": 23476,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6005,
      "choices": [
        {
          "id": 23990,
          "text": "<p><span style=\"font-size:12pt;\">Immunosuppression can be continued during pregnancy</span></p>"
        },
        {
          "id": 23991,
          "text": "<p><span style=\"font-size:12pt;\">Pregnancy to be planned once the disease has been quiescent for at least 6 months and there is no evidence of renal dysfunction</span></p>"
        },
        {
          "id": 23992,
          "text": "<p><span style=\"font-size:12pt;\">High dose corticosteroids for lupus flare in pregnancy is safe</span></p>"
        },
        {
          "id": 23993,
          "text": "<p><span style=\"font-size:12pt;\">Ecospirin, methotrexate, cyclophosphamide, corticosteroids, azathioprine are safe in pregnancy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is not true about lupus nephritis in pregnancy?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q3092800",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589770,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Ecospirin, methotrexate, cyclophosphamide, corticosteroids, azathioprine are safe in pregnancy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">SLE is a chronic autoimmune disorder involving the multisystem. It affects young women of childbearing age. The renal involvement of the disease can manifest in the form of active lupus nephritis or flare-ups during pregnancy.</span></li><li><span style=\"font-size:12pt;\">It can lead to preterm births, preeclampsia, and pregnancy loss while the infant can suffer from neonatal lupus and heart block.</span></li><li><span style=\"font-size:12pt;\">Management includes</span></li><li><span style=\"font-size:12pt;\">Preconceptionally counseling: Conception during a period of quiescence for at least 6 months determines a successful outcome. Stable remission of renal disease for at least 6 months before conception is recommended.</span></li><li><span style=\"font-size:12pt;\">Corticosteroids are useful during episodes of lupus flare and can be used safely in pregnancy.</span></li><li><span style=\"font-size:12pt;\">Immunosuppressants such as azathioprine can be continued during pregnancy. It may be used in case of severe SLE</span></li><li><span style=\"font-size:12pt;\">Hydroxychloroquine is found to be the best for maintenance and is safe in pregnancy. It can prevent the need for prolonged corticosteroid therapy.</span></li><li><span style=\"font-size:12pt;\">Methotrexate and cyclophosphamide are teratogenic and hence they are not safe during pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Immunosuppression can be continued during pregnancy</strong>: Correct. Medications like azathioprine can be continued under medical guidance, while others are used cautiously.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Pregnancy to be planned once the disease has been quiescent for at least 6 months and there is no evidence of renal dysfunction</strong>: Correct. Quiescence of the disease and stable renal function are crucial for a successful pregnancy outcome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. High dose corticosteroids for lupus flare in pregnancy is safe</strong>: Correct. High doses of corticosteroids can be used during a lupus flare, but must be carefully monitored.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Methotrexate and cyclophosphamide are not safe during pregnancy for managing lupus nephritis; corticosteroids and azathioprine are safer options.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 2895, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23993,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6040,
      "choices": [
        {
          "id": 24130,
          "text": "<p><span style=\"font-size:12pt;\">Factor II</span></p>"
        },
        {
          "id": 24131,
          "text": "<p><span style=\"font-size:12pt;\">Factor XI</span></p>"
        },
        {
          "id": 24132,
          "text": "<p><span style=\"font-size:12pt;\">Factor VII</span></p>"
        },
        {
          "id": 24133,
          "text": "<p><span style=\"font-size:12pt;\">Factor VIII</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following coagulation factors increase in pregnancy except:&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q8156956",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589764,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Factor XI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Pregnancy induces a hypercoagulable state to prepare the body for the increased risk of bleeding during delivery. This state is characterized by an increase in several coagulation factors, which enhances clot formation.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Factor II (Prothrombin):</strong> Increases during pregnancy. This contributes to a higher risk of clotting.</span></li><li><span style=\"font-size:12pt;\"><strong>Factor VII:</strong> Increases during pregnancy, aiding in the clotting process.</span></li><li><span style=\"font-size:12pt;\"><strong>Factor VIII:</strong> Also increases during pregnancy, enhancing clotting factors and overall coagulation.</span></li><li><span style=\"font-size:12pt;\"><strong>Factor XI:</strong> Does not increase during pregnancy. In fact, Factor XI levels are slightly decreased in pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Factor II:&nbsp;</strong>Factor II increases during pregnancy, contributing to the hypercoagulable state.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Factor VII:&nbsp;</strong>Factor VII levels increase during pregnancy, supporting the increased coagulation needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Factor VIII</strong>: Factor VIII increases during pregnancy, which is consistent with the overall increase in clotting factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Factor XI is the coagulation factor that does not increase during pregnancy and may actually decrease slightly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 508, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24131,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6040/INI_-_CET_May_-_2022_OBG_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6040/INI_-_CET_May_-_2022_OBG_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56957,
      "choices": [
        {
          "id": 227217,
          "text": "<p><span style=\"font-size:12.0pt;\">Methimazole</span></p>"
        },
        {
          "id": 227218,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbimazole</span></p>"
        },
        {
          "id": 227219,
          "text": "<p><span style=\"font-size:12.0pt;\">Iodine 131</span></p>"
        },
        {
          "id": 227220,
          "text": "<p><span style=\"font-size:12.0pt;\">Propylthiouracil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">G2 at 8 weeks diagnosed to have hyperthyroidism. What is the drug of choice? (NEET PG 2024)</span></p>",
      "unique_key": "Q2186427",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589299,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Propylthiouracil</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Propylthiouracil (PTU) is the preferred medication for treating hyperthyroidism in the first trimester of pregnancy. It is considered the safest option during this period because it minimizes the risk of congenital abnormalities. Methimazole and carbimazole are associated with a rare but serious condition called aplasia cutis, where infants are born with areas of missing skin. Iodine-131 is absolutely contraindicated in pregnancy due to its radioactive nature, which can lead to fetal thyroid destruction and other complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Methimazole:</strong> Although methimazole is commonly used for hyperthyroidism, it is not recommended during the first trimester of pregnancy due to its association with fetal defects like aplasia cutis, where patches of skin are absent in the newborn.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Carbimazole:</strong> Similar to methimazole, carbimazole is contraindicated in the first trimester due to the risk of fetal malformations, specifically aplasia cutis. It is often avoided in early pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Iodine 131:</strong> This radioactive iodine treatment is absolutely contraindicated in pregnancy as it can cause severe fetal harm, including thyroid gland destruction and developmental issues, making it highly unsafe.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In the first trimester of pregnancy, propylthiouracil (PTU) is the drug of choice for hyperthyroidism due to its safer profile compared to other antithyroid medications.</span></p>",
      "correct_choice_id": 227220,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/56957/Neet_Pg_Aug_2024_Obg_Q_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/56957/Neet_Pg_Aug_2024_Obg_Q_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57089,
      "choices": [
        {
          "id": 227745,
          "text": "<p><span style=\"font-size:12.0pt;\">RR (Respiratory Rate)</span></p>"
        },
        {
          "id": 227746,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine output</span></p>"
        },
        {
          "id": 227747,
          "text": "<p><span style=\"font-size:12.0pt;\">DTR (Deep Tendon Reflexes)</span></p>"
        },
        {
          "id": 227748,
          "text": "<p><span style=\"font-size:12.0pt;\">Routine serum Mg level</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">MgSO₄ toxicity: all are monitored except? (NEET PG 2024)</span></p>",
      "unique_key": "Q8499230",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589300,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D) Routine serum Mg level</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Magnesium sulfate (MgSO₄) is commonly used in obstetrics to prevent seizures in preeclampsia. Monitoring for toxicity is crucial, and the primary clinical parameters to monitor include respiratory rate (RR), urine output, and deep tendon reflexes (DTR). A decrease in these parameters can indicate magnesium toxicity. Routine measurement of serum magnesium levels is not standard practice unless clinical signs of toxicity are present or there is concern based on monitored parameters. Serum levels are checked only if there is clinical suspicion of toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. RR (Respiratory Rate):</strong> Monitoring respiratory rate is critical because respiratory depression is one of the first signs of magnesium toxicity. A rate below 12 breaths per minute can indicate toxicity and necessitates intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Urine output:</strong> Urine output is monitored because reduced kidney function can lead to magnesium accumulation and toxicity. An output of less than 30 mL/hour suggests the need for caution and potential dose adjustment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. DTR (Deep Tendon Reflexes):</strong> DTRs are closely monitored as they are among the first clinical signs to diminish with rising magnesium levels. Loss of reflexes indicates that magnesium levels are dangerously high.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Routine serum magnesium levels are not typically monitored during magnesium sulfate therapy unless clinical signs of toxicity are present.</span></p>",
      "correct_choice_id": 227748,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57089/Neet_Pg_Aug_2024_Obg_Q_42.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57089/Neet_Pg_Aug_2024_Obg_Q_42.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6013,
      "choices": [
        {
          "id": 24022,
          "text": "<p><span style=\"font-size:12pt;\">Flap closure of foramen ovale</span></p>"
        },
        {
          "id": 24023,
          "text": "<p><span style=\"font-size:12pt;\">Patent ductus arteriosus</span></p>"
        },
        {
          "id": 24024,
          "text": "<p><span style=\"font-size:12pt;\">Premature closure of the ductus arteriosus</span></p>"
        },
        {
          "id": 24025,
          "text": "<p><span style=\"font-size:12pt;\">Premature closure of the ductus venosus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year primigravida is on indomethacin (25mg TDS) for polyhydramnios till 35 weeks. What abnormality can the fetus have if she goes into labor now?&nbsp;</span>(NEET PG 2021)</p>",
      "unique_key": "Q9340256",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589308,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Premature closure of the ductus arteriosus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Indomethacin and Fetal Effects:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Indomethacin</strong> is a non-selective cyclo-oxygenase inhibitor used in obstetrics primarily for two indications:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Polyhydramnios:</strong> To reduce the excessive amniotic fluid.</span></li><li><span style=\"font-size:12pt;\"><strong>Tocolytic in preterm labor:</strong> To delay preterm labor.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Mechanism:</strong> Indomethacin works by inhibiting the production of prostaglandins, which are important for maintaining the patency of the ductus arteriosus in the fetus.</span></li><li><span style=\"font-size:12pt;\"><strong>Risks:&nbsp;</strong>When used beyond 32 weeks of gestation, indomethacin can cause <strong>premature closure of the ductus arteriosus</strong>, leading to complications such as:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Pulmonary hypertension</span></li><li><span style=\"font-size:12pt;\">Right ventricular hypertrophy</span></li><li><span style=\"font-size:12pt;\">Heart failure</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Flap closure of foramen ovale:&nbsp;</strong>The foramen ovale normally closes soon after birth when the pressure in the left atrium exceeds the pressure in the right atrium. Indomethacin does not affect the closure of the foramen ovale.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Patent ductus arteriosus:&nbsp;</strong>Patent ductus arteriosus (PDA) is a condition where the ductus arteriosus remains open after birth. Indomethacin is actually used to treat PDA by promoting its closure, not causing it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Premature closure of the ductus venosus:&nbsp;</strong>The ductus venosus allows oxygenated blood from the umbilical vein to bypass the liver and flow directly into the inferior vena cava. Indomethacin does not influence the closure of the ductus venosus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Indomethacin can cause premature closure of the ductus arteriosus if used beyond 32 weeks of gestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 679, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24024,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6013/Neet_Pg_2021_Obg_Q_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6013/Neet_Pg_2021_Obg_Q_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72668,
      "choices": [
        {
          "id": 289661,
          "text": "<p><span style=\"font-size:16px;\">Neonatal sepsis</span></p>"
        },
        {
          "id": 289662,
          "text": "<p><span style=\"font-size:16px;\">Hypoglycemia</span></p>"
        },
        {
          "id": 289663,
          "text": "<p><span style=\"font-size:16px;\">Hypothyroidism</span></p>"
        },
        {
          "id": 289664,
          "text": "<p><span style=\"font-size:16px;\">VSD</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A mother with gestational diabetes gave birth. The newborn has jitteriness, poor feeding and crying episodes. Which is likely to be seen in the fetus? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q2774616",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589863,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Hypoglycemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In infants born to mothers with gestational diabetes, <strong>hypoglycemia</strong> is a common complication. During pregnancy, the <strong>high maternal glucose</strong> levels cause <strong>increased insulin</strong> production in the fetus. After birth, when the constant glucose supply from the mother stops but the infant's insulin levels remain high, <strong>hypoglycemia develops</strong>. The classic clinical manifestations include:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Jitteriness</strong></span></li><li><span style=\"font-size:16px;\"><strong>Poor feeding</strong></span></li><li><span style=\"font-size:16px;\"><strong>Excessive crying</strong></span></li><li><span style=\"font-size:16px;\"><strong>Lethargy</strong></span></li><li><span style=\"font-size:16px;\"><strong>Seizures in severe cases</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Neonatal Sepsis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">While <strong>neonatal sepsis&nbsp;</strong>can cause similar symptoms, it is not directly related to <strong>maternal gestational diabetes</strong></span></li><li><span style=\"font-size:16px;\">Would typically present with additional signs like <strong>temperature instability and respiratory distress</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Hypothyroidism:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Hypothyroidism in newborns presents with different symptoms like <strong>prolonged jaundice and constipation</strong></span></li><li><span style=\"font-size:16px;\">Not a direct complication of gestational diabetes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. VSD (Ventricular Septal Defect):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">While diabetic mothers have increased risk of fetal cardiac anomalies, VSD would not cause the acute symptoms described</span></li><li><span style=\"font-size:16px;\">VSD typically presents with <strong>failure to thrive and respiratory symptoms</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Infants of diabetic mothers are at risk of developing hypoglycemia in the immediate postnatal period due to persistent hyperinsulinemia after birth, manifesting as jitteriness, poor feeding, and crying episodes.</span></p>",
      "correct_choice_id": 289662,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/72668/FMGE_Jan_2025_OBG_Q_-_28.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/72668/FMGE_Jan_2025_OBG_Q_-_28.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5730,
      "choices": [
        {
          "id": 22892,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ascending aorta syndrome</span></span></span></p>"
        },
        {
          "id": 22893,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Superior vena-caval syndrome</span></span></span></p>"
        },
        {
          "id": 22894,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Abdominal aorta syndrome</span></span></span></p>"
        },
        {
          "id": 22895,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Supine vena cava syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant lady with PIH was being monitored with bed rest in supine position. Which of the following is a complication of the below representation?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/inicet-obg-nov-2017-1.jpg\" style=\"height:149px; width:300px\" /></p>",
      "unique_key": "Q6824729",
      "question_audio": null,
      "question_video": null,
      "map_id": 37489348,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Supine vena cava syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image illustrates supine hypotension syndrome, also known as supine vena cava syndrome. This condition occurs in the third trimester of pregnancy when the gravid uterus compresses the inferior vena cava (IVC) while the woman is in a supine position. This compression leads to reduced venous return to the heart, causing hypotension, tachycardia, and syncope. It is especially dangerous during cesarean sections, as spinal anesthesia can exacerbate hypotension. To prevent this, a wedge is placed beneath the right hip during the procedure to tilt the patient slightly to the left, thereby relieving pressure on the vena cava.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Ascending aorta syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This condition is not typically associated with pregnancy and does not involve the pressure of the gravid uterus on the IVC.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Superior vena-caval syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This syndrome involves obstruction of the superior vena cava, leading to symptoms such as facial swelling and dyspnea. It is unrelated to the position of a pregnant woman and the compression of the IVC.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Abdominal aorta syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: There is no specific syndrome by this name. The abdominal aorta may be compressed during pregnancy, but it does not lead to the symptoms associated with supine hypotension syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Supine vena cava syndrome occurs in the third trimester of pregnancy due to the pressure of the gravid uterus on the inferior vena cava when the woman is in a supine position, leading to hypotension, tachycardia, and syncope.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 2237, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22895,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6024,
      "choices": [
        {
          "id": 24066,
          "text": "<p><span style=\"font-size:12pt;\">Primary syphilis</span></p>"
        },
        {
          "id": 24067,
          "text": "<p><span style=\"font-size:12pt;\">Secondary syphilis</span></p>"
        },
        {
          "id": 24068,
          "text": "<p><span style=\"font-size:12pt;\">Latent syphilis</span></p>"
        },
        {
          "id": 24069,
          "text": "<p><span style=\"font-size:12pt;\">Congenital syphilis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Kassowitz rule is related to?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q7438783",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589765,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Congenital syphilis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Kassowitz's rule pertains to congenital syphilis. According to this rule, if a woman with untreated syphilis has multiple pregnancies, the likelihood of congenital syphilis affecting the fetus in later pregnancies decreases. This phenomenon is observed as a result of the immune system's adaptive response and potential changes in the transmission dynamics of the infection over successive pregnancies. Therefore, the rule suggests that with each subsequent pregnancy, the outcome for the fetus improves if the infection remains untreated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Primary syphilis</strong>: Primary syphilis involves the initial chancre or ulcer at the site of infection and is not related to Kassowitz's rule, which specifically addresses outcomes in congenital syphilis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Secondary syphilis</strong>: Secondary syphilis is characterized by systemic manifestations such as skin rashes and mucous membrane lesions and is not related to Kassowitz's rule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Latent syphilis</strong>: Latent syphilis refers to a stage where no symptoms are present but the infection is still systemic. Kassowitz's rule is not associated with latent syphilis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Kassowitz rule states that the likelihood of congenital syphilis infection decreases with each successive pregnancy in a woman with untreated syphilis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 343, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24069,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6024/INI_-_CET_May_-_2022_OBG_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6024/INI_-_CET_May_-_2022_OBG_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6041,
      "choices": [
        {
          "id": 24134,
          "text": "<p><span style=\"font-size:12pt;\">Hospitalize, send urine and blood cultures and start on antibiotics.</span></p>"
        },
        {
          "id": 24135,
          "text": "<p><span style=\"font-size:12pt;\">Oral antibiotics once afebrile</span></p>"
        },
        {
          "id": 24136,
          "text": "<p><span style=\"font-size:12pt;\">Maintain urine output &gt; 50 ml/h; Intravenous crystalloids can be given</span></p>"
        },
        {
          "id": 24137,
          "text": "<p><span style=\"font-size:12pt;\">Discharge if afebrile for 72 h; Continue antibiotics for 5 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant lady at 20 weeks of gestation comes with complaints of acute onset fever, and pain in the right lumbar region. It is associated with chills, nausea, and vomiting. Urinalysis reveals the presence of E. coli and a diagnosis of acute pyelonephritis is made. Which of the following is incorrect regarding the management of acute pyelonephritis in pregnancy?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q6934510",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589763,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Discharge if afebrile for 72 h; Continue antibiotics for 5 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The management of acute pyelonephritis during pregnancy involves several key steps to ensure effective treatment and prevent complications:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Hospitalization:</strong> Necessary for intravenous antibiotics and monitoring.</span></li><li><span style=\"font-size:12pt;\"><strong>Urine and Blood Cultures:</strong> Essential for identifying the pathogen and tailoring antibiotic therapy.</span></li><li><span style=\"font-size:12pt;\"><strong>Intravenous Crystalloids:</strong> Used to maintain adequate urine output (≥50 mL/h) and ensure proper hydration.</span></li><li><span style=\"font-size:12pt;\"><strong>Antibiotics:</strong> Initially given intravenously, with the switch to oral antibiotics once the patient is afebrile.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The incorrect statement is <strong>Option D</strong>. The correct management protocol dictates:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Discharge Criteria:&nbsp;The patient can be discharged once afebrile for 24 hours, not 72 hours.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Duration of Antibiotics:&nbsp;The recommended course of antibiotics is 7 to 10 days, not just 5 days.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Hospitalize, send urine and blood cultures and start on antibiotics:</strong> Correct. Hospitalization, urine and blood cultures, and starting antibiotics are all appropriate steps in managing acute pyelonephritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Oral antibiotics once afebrile:</strong> Correct. Switching to oral antibiotics is appropriate once the patient is afebrile.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Maintain urine output &gt; 50 ml/h; Intravenous crystalloids can be given:</strong> Correct. Maintaining a urine output of &gt; 50 mL/h and using intravenous crystalloids are standard practices to manage hydration and ensure adequate renal function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Discharge from the hospital should be considered once the patient is afebrile for 24 hours, and antibiotics should be continued for 7 to 10 days in cases of acute pyelonephritis in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2594, Williams Obstetrics, 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24137,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6076,
      "choices": [
        {
          "id": 24273,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loss of knee jerk</span></span></span></p>"
        },
        {
          "id": 24274,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypotension</span></span></span></p>"
        },
        {
          "id": 24275,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory depression</span></span></span></p>"
        },
        {
          "id": 24276,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced muscle tone</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman with eclampsia is started on magnesium sulfate. What is the first sign of magnesium sulfate toxicity?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q4909687",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589759,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Loss of knee jerk</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therapeutic range</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The therapeutic range of magnesium for the prevention of seizures in eclampsia is 4-7 mEq/L.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loss of Deep Tendon Reflexes (DTRs)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The first sign of magnesium sulfate toxicity is the loss of DTRs, specifically the knee jerk reflex. This occurs when plasma magnesium levels reach 7-10 mEq/L.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory depression</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: When plasma magnesium levels reach 10-12 mEq/L, respiratory depression occurs. Beyond 12 mEq/L, respiratory paralysis and respiratory arrest can occur.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac arrest</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cardiac arrest can happen if serum magnesium levels exceed 25 mEq/L.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monitoring</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A patient on magnesium sulfate is monitored for toxicity by checking clinical signs, including DTRs, urine output, and respiratory rate.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment of toxicity</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Treatment for magnesium sulfate toxicity involves administering calcium gluconate or calcium chloride (1g intravenously) and discontinuing magnesium sulfate, which usually reverses mild to moderate respiratory depression.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hypotension</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Hypotension is not the first sign of magnesium sulfate toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Respiratory depression</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Respiratory depression occurs at higher magnesium levels (10-12 mEq/L), after the loss of knee jerk reflex.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Reduced muscle tone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Reduced muscle tone is not the first sign of magnesium sulfate toxicity and is less specific than the loss of DTRs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The first sign of magnesium sulfate toxicity is the loss of deep tendon reflexes (knee jerk).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 24<sup>th</sup> edition page 759</span></strong></span></span></p>",
      "correct_choice_id": 24273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47897,
      "choices": [
        {
          "id": 191183,
          "text": "<p><span style=\"font-size:12.0pt;\">50g</span></p>"
        },
        {
          "id": 191184,
          "text": "<p><span style=\"font-size:12.0pt;\">75g&nbsp;&nbsp;&nbsp;&nbsp;</span></p>"
        },
        {
          "id": 191185,
          "text": "<p><span style=\"font-size:12.0pt;\">100g</span></p>"
        },
        {
          "id": 191186,
          "text": "<p><span style=\"font-size:12.0pt;\">150g</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In screening for diabetes in pregnancy, the dose of oral glucose load given is?&nbsp;(FMGE JANUARY 2024)</span></p>",
      "unique_key": "Q5467698",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590080,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 75g</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For screening and diagnosis of gestational diabetes mellitus (GDM), the oral glucose tolerance test (OGTT) is commonly used. The standard protocol involves a 75-gram oral glucose load.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Protocol for 75-gram OGTT:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>International Guidelines: According to the International Association of Diabetes in Pregnancy Study Groups (IADPSG):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The test is performed after an overnight fast.</span></li><li><span style=\"font-size:12.0pt;\">A fasting blood sample is taken.</span></li><li><span style=\"font-size:12.0pt;\">The woman is then given a 75-gram oral glucose load.</span></li><li><span style=\"font-size:12.0pt;\">Blood samples are taken at 1 hour and 2 hours after the glucose load.</span></li><li><span style=\"font-size:12.0pt;\">Diagnostic thresholds:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Fasting glucose ≥ 92 mg/dL</span></li><li><span style=\"font-size:12.0pt;\">1-hour glucose ≥ 180 mg/dL</span></li><li><span style=\"font-size:12.0pt;\">2-hour glucose ≥ 153 mg/dL</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A diagnosis of GDM is made if any one of these values is met or exceeded.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>DIPSI Criteria (India):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This method can be used irrespective of the prandial state (whether the woman is fasting or not).</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A 75-gram oral glucose load is given.</span></li><li><span style=\"font-size:12.0pt;\">A blood sample is taken 2 hours later.</span></li><li><span style=\"font-size:12.0pt;\">A 2-hour plasma glucose value ≥ 140 mg/dL indicates GDM.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 50g</strong>: Used in the 50-gram glucose challenge test, which is a preliminary screening test, but not diagnostic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 100g</strong>: Used in the 3-hour OGTT, which is less commonly used now compared to the 75-gram test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 150g</strong>: Not used for GDM screening or diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The current standard for screening and diagnosing gestational diabetes mellitus is the 75-gram oral glucose tolerance test (OGTT).</span></p>",
      "correct_choice_id": 191184,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/47897/FMGE_Jan_-_2024_OBG_Question_27.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/47897/FMGE_Jan_-_2024_OBG_Question_27.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6125,
      "choices": [
        {
          "id": 24469,
          "text": "<p><span style=\"font-size:12pt;\">Conservative management</span></p>"
        },
        {
          "id": 24470,
          "text": "<p><span style=\"font-size:12pt;\">Administer tocolytics and deliver at 37 wks</span></p>"
        },
        {
          "id": 24471,
          "text": "<p><span style=\"font-size:12pt;\">Give steroid cover and wait until steroid cover is complete.</span></p>"
        },
        {
          "id": 24472,
          "text": "<p><span style=\"font-size:12pt;\">Treat hypertension, administer MgSO4, and consider termination of pregnancy.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman with 35 weeks+5 days gestation complains of epigastric pain, headache, and blurring of vision. Her blood pressure is 170/110 mmHg. She is in labor pain. Examination of the cervix shows a 3 cm dilatation with a bag of liquor. What is the appropriate management?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q7974292",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589598,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Treat hypertension, administer MgSO4, and consider termination of pregnancy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This pregnant woman is presenting with symptoms and signs of severe pre-eclampsia, which include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Epigastric pain</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Headache</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Blurring of vision</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Severe hypertension</strong>: Blood pressure of 170/110 mmHg.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the context of severe pre-eclampsia at 35 weeks+5 days gestation, the management should include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Treating hypertension</strong>: Immediate blood pressure control is crucial to prevent complications such as eclampsia, stroke, or placental abruption.</span></li><li><span style=\"font-size:12pt;\"><strong>Administering magnesium sulfate (MgSO4)</strong>: This is done to prevent eclamptic seizures.</span></li><li><span style=\"font-size:12pt;\"><strong>Consideration for termination of pregnancy</strong>: In cases of severe pre-eclampsia at or beyond 34 weeks, the recommended course of action is to expedite delivery to prevent further maternal and fetal complications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Conservative management</strong>: Conservative management is not appropriate for severe pre-eclampsia due to the high risk of complications for both the mother and the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Administer tocolytics and deliver at 37 weeks</strong>: Tocolytics are contraindicated in severe pre-eclampsia as the goal is to deliver the baby as soon as the condition is stable, rather than delaying delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Give steroid cover and wait until steroid cover is complete</strong>: As the patient is already beyond 34 weeks of gestation, steroid administration for fetal lung maturity is not necessary, and immediate delivery is preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In cases of severe pre-eclampsia at or beyond 34 weeks of gestation, immediate management involves controlling hypertension, administering magnesium sulfate to prevent seizures, and expediting delivery.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-291.jpg\" alt=\"\" width=\"500\" height=\"593\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Williams textbook of obstetrics 26<sup>th</sup> edition pg 1850, &nbsp;Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg267</strong></span></p>",
      "correct_choice_id": 24472,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6125/INICET_Nov_2022_OBG_Question_22.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6125/INICET_Nov_2022_OBG_Question_22.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44014,
      "choices": [
        {
          "id": 175715,
          "text": "<p><span style=\"font-size:12pt;\">Rubella</span></p>"
        },
        {
          "id": 175716,
          "text": "<p><span style=\"font-size:12pt;\">Cytomegalovirus (CMV)</span></p>"
        },
        {
          "id": 175717,
          "text": "<p><span style=\"font-size:12pt;\">HSV 2</span></p>"
        },
        {
          "id": 175718,
          "text": "<p><span style=\"font-size:12pt;\">Chicken pox</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which infection contracted in pregnancy won't be teratogenic?</span>(INICET NOV 2023)</p>",
      "unique_key": "Q6538490",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589597,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) HSV 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Herpes Simplex Virus type 2 (HSV 2) primarily causes genital infections and is not generally teratogenic. It poses risks primarily at delivery if there is an active infection, leading to neonatal herpes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Rubella:</strong> Rubella is highly teratogenic, especially if contracted in the first trimester.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Cytomegalovirus (CMV):&nbsp;</strong>Cytomegalovirus (CMV) is a common cause of congenital infections and can result in severe fetal abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Chicken pox:</strong> Chickenpox (Varicella) can lead to congenital varicella syndrome, which is teratogenic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Among the listed infections, HSV 2 is not considered teratogenic, although it requires careful management to prevent neonatal transmission during delivery.</span></p>",
      "correct_choice_id": 175717,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/44014/INI_-_CET_Nov_-_2023_OBG_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/44014/INI_-_CET_Nov_-_2023_OBG_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54773,
      "choices": [
        {
          "id": 218557,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + MgSO4 + Expedite delivery</span></p>"
        },
        {
          "id": 218558,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + MgSO4 + Wait till 37 weeks</span></p>"
        },
        {
          "id": 218559,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + Corticosteroids + wait till 37 weeks</span></p>"
        },
        {
          "id": 218560,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol + Corticosteroids + Expedite delivery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents at 36 weeks with chronic HTN and 3+ proteinuria. Her BP is 170/100 mmHg and she complains of headache and blurring of vision. What is the best management option? (INICET MAY 2024)</span></p>",
      "unique_key": "Q7599765",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589760,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Labetalol + MgSO4 + Expedite delivery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient is presenting with chronic hypertension that has progressed to superimposed preeclampsia, indicated by the development of 3+ proteinuria, a blood pressure of 170/100 mmHg, and symptoms such as headache and blurring of vision. These symptoms and her elevated blood pressure suggest severe preeclampsia.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Severe Preeclampsia</strong>: A systolic blood pressure greater than 160 mmHg or a diastolic blood pressure greater than 110 mmHg, along with symptoms like headache and visual disturbances, are indicators of severe preeclampsia. In this case, the patient’s condition requires urgent management to prevent the development of eclampsia, a condition that can lead to seizures and other severe complications.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Management</strong>: The correct management for severe preeclampsia at 36 weeks gestation includes the administration of <strong>Labetalol</strong> to lower the blood pressure, <strong>Magnesium sulfate (MgSO4)</strong> to prevent seizures, and <strong>expedited delivery</strong> to resolve the preeclampsia. After 34 weeks of gestation, delivery is recommended for severe preeclampsia because the risks of continuing the pregnancy outweigh the benefits.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Labetalol + MgSO4 + Wait till 37 weeks: </strong>As this is severe preeclampsia, there is a very high risk waiting till 37 weeks. Immediate delivery is indicated after 34 weeks</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Labetalol + Corticosteroids + wait till 37 weeks: </strong>There is no indication for corticosteroids as she has crossed 34 weeks and also there is no indication to wait till 37 weeks as this is severe preeclampsia</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Labetalol + Corticosteroids + Expedite delivery:&nbsp;</strong>Although delivery needs to be expedited, there is no indication for corticosteroids as she has crossed 34 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of severe preeclampsia after 34 weeks, immediate delivery, blood pressure control with labetalol, and seizure prophylaxis with magnesium sulfate are essential for optimal maternal and fetal outcomes.</span></p>",
      "correct_choice_id": 218557,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54773/INI-CET_May_2024_OBG_Q_-_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54773/INI-CET_May_2024_OBG_Q_-_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5874,
      "choices": [
        {
          "id": 23466,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malformations</span></span></span></p>"
        },
        {
          "id": 23467,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyhydramnios</span></span></span></p>"
        },
        {
          "id": 23468,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal Macrosomia</span></span></span></p>"
        },
        {
          "id": 23469,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neonatal Hypoglycemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the followings are seen in Gestational Diabetes Mellitus except:&nbsp;</span></span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q5655355",
      "question_audio": null,
      "question_video": null,
      "map_id": 37594071,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Malformations</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital malformations are not typically seen with Gestational Diabetes Mellitus (GDM); they are more associated with pre-existing overt diabetes mellitus. When diabetes is present and uncontrolled in the first trimester, particularly with an HbA1C greater than 10%, there is a higher risk of congenital malformations. The most commonly affected system is cardiac, with Ventricular Septal Defect (VSD) being the most common anomaly. A very rare but characteristic anomaly associated with severe diabetes is Mermaid syndrome (sirenomelia).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Polyhydramnios:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Polyhydramnios, characterized by an Amniotic Fluid Index (AFI) greater than 25 or a Single Deepest Pocket (SDP) greater than 8, is common in pregnancies complicated by GDM. It results from increased fetal urination due to hyperglycemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Fetal Macrosomia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Fetal macrosomia, defined as a birth weight greater than 4 kg, is a common complication of GDM. It is associated with excessive fat deposition, particularly around the shoulders, increasing the risk of shoulder dystocia during delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Neonatal Hypoglycemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Neonatal hypoglycemia, with blood glucose levels less than 45 mg/dl, is common in infants of mothers with GDM, especially if maternal blood sugar levels were unstable during labor. This occurs because the fetus produces excess insulin in response to maternal hyperglycemia, leading to low blood sugar levels after birth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital anomalies are not typically seen with Gestational Diabetes Mellitus (GDM); they are associated with pre-existing overt diabetes mellitus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 26<sup>th</sup> edition pg 2787</span></strong></span></span></p>",
      "correct_choice_id": 23466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6052,
      "choices": [
        {
          "id": 24178,
          "text": "<p><span style=\"font-size:12pt;\">Magnesium toxicity</span></p>"
        },
        {
          "id": 24179,
          "text": "<p><span style=\"font-size:12pt;\">Diabetic ketoacidosis</span></p>"
        },
        {
          "id": 24180,
          "text": "<p><span style=\"font-size:12pt;\">Postpartum eclampsia</span></p>"
        },
        {
          "id": 24181,
          "text": "<p><span style=\"font-size:12pt;\">Peripartum cardiomyopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22y type 1 DM is in the post operative ward following a cesarean done for failed induction (for preeclampsia with severe features). She complains of drowsiness and altered sensorium. She is on maintenance MgSO4 infusion and on IV infusion of insulin. On examination, her PR is 70/ min. BP is 140/ 98 mmHg. RR is 10/min. Auscultation of lungs reveals bilateral normal air entry. Abdominal examination reveals a firm uterus with normal tenderness. Pfannenstiel scar is intact and there is no significant vaginal bleeding. B/l patellar reflexes are absent. A urine dipstick for protein and sugar is negative and a capillary glucose sample is 270 mg%. The suspected diagnosis is?&nbsp;(NEET PG 2022)</span></p>",
      "unique_key": "Q3994813",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589305,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Magnesium toxicity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The given clinical scenario and examination finding of B/L absent knee reflex and respiratory depression following magnesium sulfate (MgSO4) administration for preeclampsia suggest the cause of her condition to be magnesium sulfate toxicity.</span></li><li><span style=\"font-size:12pt;\">MgSO4 is used as an anticonvulsant in the management of eclampsia and as prophylaxis in severe preeclampsia.</span></li><li><span style=\"font-size:12pt;\">The therapeutic level of magnesium in eclampsia is 4-7 mEq/L</span></li><li><span style=\"font-size:12pt;\">When on MgSO4, patients must be monitored for magnesium toxicity:</span></li><li><span style=\"font-size:12pt;\">A woman on MgSO4 for management of eclampsia requires the following to be checked for Mg toxicity:</span><ol><li><span style=\"font-size:12pt;\">Deep tendon reflexes</span></li><li><span style=\"font-size:12pt;\">Respiratory Rate</span></li><li><span style=\"font-size:12pt;\">Urine Output</span></li></ol></li><li><span style=\"font-size:12pt;\">Magnesium toxicity occurs at these levels</span><ul><li><span style=\"font-size:12pt;\">At &gt; 7-10 mEq/L: Loss of DTR</span></li><li><span style=\"font-size:12pt;\">10 - 12 mEq/L: Respiratory depression</span></li><li><span style=\"font-size:12pt;\">25 mEq/L: Cardiac arrest</span></li></ul></li><li><span style=\"font-size:12pt;\">Antidote for Mg toxicity: Ca gluconate (1 g IV)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Diabetic ketoacidosis</strong>: This is unlikely as urine for sugars is absent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Postpartum eclampsia</strong>: This is unlikely as there is no history of seizures</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Peripartum cardiomyopathy</strong>: There is no evidence of cardiac failure and hence this is also unlikely</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">When administering magnesium sulfate for preeclampsia, it is critical to monitor for signs of magnesium toxicity, which include loss of deep tendon reflexes, respiratory depression, and cardiac arrest. The antidote for magnesium toxicity is calcium gluconate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 1860, Williams Obstetrics, 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24178,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6052/Neet_Pg_2022_Obg_Q_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6052/Neet_Pg_2022_Obg_Q_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6006,
      "choices": [
        {
          "id": 23994,
          "text": "<p><span style=\"font-size:12pt;\">Elective C-section has no role in reducing incidence of brachial plexus injury</span></p>"
        },
        {
          "id": 23995,
          "text": "<p><span style=\"font-size:12pt;\">In a patient being planned for induction of labor, night dose of intermediate insulin is given as planned, and the morning dose is withheld</span></p>"
        },
        {
          "id": 23996,
          "text": "<p><span style=\"font-size:12pt;\">In active labor, if RBS &lt;70 mg%, D5 is started at 100-150 ml/h till the RBS is &gt;100 mg%</span></p>"
        },
        {
          "id": 23997,
          "text": "<p><span style=\"font-size:12pt;\">Capillary blood glucose monitoring levels are kept at fasting- 95 mg%; 1 h postprandial- 140 mg%; 2 h postprandial: 120 mg%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is false regarding management of diabetes in pregnancy?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q6509098",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589769,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Elective C-section has no role in reducing incidence of brachial plexus injury</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">False statement regarding management of diabetes in pregnancy is option A.</span></li><li><span style=\"font-size:12pt;\">The Cesarean section is found to be protective against traumatic injuries such as brachial plexus injury, in macrosomic babies born to mothers with diabetes.</span></li><li><span style=\"font-size:12pt;\">Elective LSCS is recommended when the estimated fetal weight is &gt; 4.5kg in diabetic mothers to reduce the incidence of birth trauma</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. In a patient being planned for induction of labor, night dose of intermediate insulin is given as planned, and the morning dose is withheld</strong>: In a planned delivery, although the bedtime dose of intermediate-acting insulin is given, it is recommended that the morning dose must be withheld</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Insulin Management for Labor Induction or Scheduled Cesarean Delivery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/untitled-236.jpg\" alt=\"\" width=\"900\" height=\"271\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. In active labor, if RBS &lt;70 mg%, D5 is started at 100-150 ml/h till the RBS is &gt;100 mg%:</strong> In active labor, if RBS (Random blood glucose) &lt;70 mg%, D5 (5% dextrose) is started at 100-150 ml/h till the RBS is &gt;100 mg%. Before initiation of labor, normal saline is used for iv infusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Capillary blood glucose monitoring levels are kept at fasting- 95 mg%; 1 h postprandial- 140 mg%; 2 h postprandial: 120 mg%:</strong> Self-monitoring of capillary blood glucose is advised in a pregnant woman diagnosed with diabetes. The glucose goals recommended are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Fasting: 95 mg/dL</strong></span></li><li><span style=\"font-size:12pt;\"><strong>1 h postprandial: 140 mg/dL</strong></span></li><li><span style=\"font-size:12pt;\"><strong>2 h postprandial: 120 mg/dL</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Elective C-section can reduce the incidence of brachial plexus injury in pregnancies complicated by diabetes, especially in cases of fetal macrosomia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2807, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23994,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6006/Ini_-_Cet_May_-_2022_Obg_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6006/Ini_-_Cet_May_-_2022_Obg_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5891,
      "choices": [
        {
          "id": 23534,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">First trimester</span></span></span></p>"
        },
        {
          "id": 23535,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Second trimester</span></span></span></p>"
        },
        {
          "id": 23536,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Third trimester</span></span></span></p>"
        },
        {
          "id": 23537,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both (a) and (b)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In which trimester does acute fatty liver manifest most commonly during pregnancy?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (NEET PG 2019)</span></span></p>",
      "unique_key": "Q7134299",
      "question_audio": null,
      "question_video": null,
      "map_id": 37489402,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Third trimester </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute fatty liver of pregnancy (AFLP) is a life-threatening medical disorder that primarily affects the liver during pregnancy. It most commonly manifests in the late second and third trimesters. AFLP is characterized by the accumulation of microvesicular fat within hepatocytes, leading to liver dysfunction. The diagnosis of AFLP is made using the Swansea criteria, which require six or more of the following clinical features for diagnosis:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vomiting</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abdominal pain</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polydipsia, polyuria</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Encephalopathy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coagulopathy (raised PT, aPTT)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased bilirubin</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased uric acid levels</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased creatinine</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leukocytosis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoglycemia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Raised liver enzymes</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Raised serum ammonia levels</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ascites or bright liver on ultrasound</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microvascular steatosis on liver biopsy</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk Factors:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maternal obesity</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Male fetus</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primigravida</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiple pregnancy</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. First trimester</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: AFLP is very rare in the first trimester, as it typically manifests later in pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Second trimester</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While AFLP can begin in the late second trimester, it is more commonly seen in the third trimester.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Both (a) and (b)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: AFLP does not commonly manifest in the first trimester and is primarily a condition of the late second and third trimesters.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute fatty liver of pregnancy most commonly manifests in the third trimester and is diagnosed using the Swansea criteria, requiring six or more specific clinical features.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 2684, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23536,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6000,
      "choices": [
        {
          "id": 23970,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inj. Dobutamine</span></span></span></p>"
        },
        {
          "id": 23971,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Steroids</span></span></span></p>"
        },
        {
          "id": 23972,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroxine</span></span></span></p>"
        },
        {
          "id": 23973,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activated protein C</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old lady had an uneventful vaginal delivery. On postpartum day 1, she presented with postpartum hemorrhage and complains of visual changes and severe headache. A few hours after the complaint, she is found to be in an unresponsive state and is intubated and put on ventilation. On further examination, she has a BP of 60/40 mmHg and tachycardia, blood sugar is 48 mg/dL. Hematocrit and WBC count was normal. Which of the following drugs would help reverse this state?&nbsp;</span></span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q3037125",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589771,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Steroids</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation described&mdash;postpartum hemorrhage followed by severe headache, visual changes, hypotension, and unresponsiveness&mdash;suggests Sheehan syndrome. This condition arises from pituitary apoplexy, which is pituitary infarction secondary to severe blood loss during or after childbirth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan Syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This syndrome is characterized by pituitary gland failure due to substantial blood loss during delivery. The symptoms include persistent hypotension, tachycardia, hypoglycemia, lactation failure, headache, visual deficits, and in severe cases, shock, CNS hemorrhage, and even death.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Steroids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Hormone replacement with glucocorticoids (steroids) is crucial for managing Sheehan syndrome. Steroids address the adrenal insufficiency and help stabilize the patient&rsquo;s condition. Initially, glucocorticoids are administered, followed by other hormone replacements as needed.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Inj. Dobutamine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Dobutamine is a beta-agonist used for managing cardiac failure and hypotension. While it may help with blood pressure, it does not address the underlying issue of pituitary failure and would not be the primary treatment for Sheehan syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Thyroxine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Thyroxine (T4) is a thyroid hormone used in thyroid hormone replacement therapy. While it might be needed later if thyroid function is affected, it does not directly address the acute symptoms of Sheehan syndrome, which is primarily managed with steroids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Activated Protein C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Activated protein C is used in the management of severe sepsis and disseminated intravascular coagulation (DIC), but it does not treat the pituitary dysfunction associated with Sheehan syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan syndrome is treated primarily with glucocorticoid (steroid) therapy to manage pituitary failure following significant blood loss during or after childbirth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 378, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23971,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6021,
      "choices": [
        {
          "id": 24054,
          "text": "<p><span style=\"font-size:12pt;\">Graph A</span></p>"
        },
        {
          "id": 24055,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Graph B</span></p>"
        },
        {
          "id": 24056,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Graph C</span></p>"
        },
        {
          "id": 24057,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Graph D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following graphs represents normal response to OGTT?&nbsp;</span>(INICET MAY 2022)</p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_QetTw5P.jpg\" alt=\"\" width=\"300\" height=\"197\"></span></p>",
      "unique_key": "Q7698609",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589766,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Graph D</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The normal response to an Oral Glucose Tolerance Test (OGTT) is depicted by Graph D. During an OGTT, a patient ingests a specified amount of glucose (commonly 75 grams), and blood glucose levels are measured at intervals to evaluate how well the body handles glucose. In a normal response:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Blood glucose levels rise to a peak within 1 hour after ingestion.</span></li><li><span style=\"font-size:12pt;\">Glucose levels then decline and return to baseline by 2 hours.</span></li><li><span style=\"font-size:12pt;\">The glucose levels do not exceed the renal threshold at any point during the test.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This pattern reflects the body's effective regulation of blood glucose levels and the normal function of insulin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Graph A:&nbsp;</strong>Graph A might depict an abnormal glucose tolerance curve, such as one seen in impaired glucose tolerance or gestational diabetes, where glucose levels remain elevated for a prolonged period or fail to return to baseline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Graph B</strong>: Graph B could show a response with an abnormal peak or delayed return to baseline, indicative of glucose intolerance or a diagnostic criterion for diabetes mellitus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Graph C</strong>: Graph C might represent an exaggerated glucose peak or prolonged elevated glucose levels, suggesting a pathological glucose tolerance response consistent with diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A normal OGTT response features a peak in blood glucose levels within 1 hour, followed by a return to baseline levels within 2 hours, without exceeding the renal threshold.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref:&nbsp;</strong></span><a href=\"https://www.researchgate.net/publication/301045468_VARIANTS_OF_ORAL_GLUCOSE_TOLERANCE_TEST_OGTT_CURVE_IN_GESTATIONAL_DIABETES_MELLITUS_GDM\"><span style=\"font-size:12pt;\"><strong><u>https://www.researchgate.net/publication/301045468_VARIANTS_OF_ORAL_GLUCOSE_TOLERANCE_TEST_OGTT_CURVE_IN_GESTATIONAL_DIABETES_MELLITUS_GDM</u></strong></span></a></p>",
      "correct_choice_id": 24057,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6021/INI_-_CET_May_-_2022_OBG_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6021/INI_-_CET_May_-_2022_OBG_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5944,
      "choices": [
        {
          "id": 23746,
          "text": "<p><span style=\"font-size:12pt;\">Stop antibiotics and start heparin</span></p>"
        },
        {
          "id": 23747,
          "text": "<p><span style=\"font-size:12pt;\">Antibiotics + Heparin</span></p>"
        },
        {
          "id": 23748,
          "text": "<p><span style=\"font-size:12pt;\">Surgical embolectomy</span></p>"
        },
        {
          "id": 23749,
          "text": "<p><span style=\"font-size:12pt;\">Hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old pregnant lady presents with fever and is put on antibiotics. Fever is still not brought under control. On further investigation, she is diagnosed to have septic pelvic thrombophlebitis. Which among the following is the next course of treatment for her? (NEET PG 2019)</span></p>",
      "unique_key": "Q5328071",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589312,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Antibiotics + Heparin</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Antibiotics + heparin:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Septic pelvic thrombophlebitis (SPT) is a rare postpartum infective complication characterized by persistent high-grade fever despite broad-spectrum antibiotic therapy. It typically occurs after delivery or abortion and is often seen in women with risk factors like cesarean section, prolonged labor, or pelvic infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The fever in SPT is caused by a septic thrombus in the pelvic veins—most commonly the ovarian vein—that harbors bacteria and incites a sustained inflammatory response. Since antibiotics alone cannot fully penetrate the infected thrombus, the addition of anticoagulation (usually low molecular weight heparin) is essential. Heparin helps in lysing the thrombus, preventing further propagation and improving antibiotic penetration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical improvement is usually seen within 48–72 hours of initiating combined therapy with antibiotics and heparin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Stop antibiotics and start heparin</strong>:&nbsp; Incorrect because infection is still present—antibiotics are needed to control the infective component. &nbsp;Stopping antibiotics would worsen sepsis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Surgical embolectomy:&nbsp;</strong>&nbsp;Too invasive and not first-line. &nbsp;Reserved for rare cases with septic emboli or failure to respond to medical management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hysterectomy:&nbsp;</strong>Not indicated unless there’s uncontrolled pelvic infection not responding to medical therapy or associated endomyometritis with uterine necrosis.&nbsp; SPT is usually confined to pelvic veins, not requiring removal of the uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The best management for pregnant women with antiphospholipid syndrome (APS) to prevent recurrent pregnancy loss includes low-dose aspirin and low molecular weight heparin (LMWH).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2951, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23747,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5680,
      "choices": [
        {
          "id": 22692,
          "text": "<p><span style=\"font-size:12pt;\">Hypertension diagnosed at 10 weeks of gestation&nbsp;</span></p>"
        },
        {
          "id": 22693,
          "text": "<p><span style=\"font-size:12pt;\">Diabetic retinopathy</span></p>"
        },
        {
          "id": 22694,
          "text": "<p><span style=\"font-size:12pt;\">Diabetic nephropathy&nbsp;</span></p>"
        },
        {
          "id": 22695,
          "text": "<p><span style=\"font-size:12pt;\">Episode of seizure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Pregnant women with which of the following is called systemic hypertension?&nbsp;(INICET MAY 2017) &nbsp; &nbsp; &nbsp; &nbsp;</span></p>",
      "unique_key": "Q1413020",
      "question_audio": null,
      "question_video": null,
      "map_id": 37489347,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Hypertension diagnosed at 10 weeks of gestation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Systemic hypertension in pregnancy is classified as chronic hypertension if it is diagnosed in the first trimester or if hypertension persists beyond 12 weeks postpartum. Hypertension present before pregnancy or diagnosed before the 20th week of gestation also qualifies as chronic hypertension. This is distinct from gestational hypertension, which develops after 20 weeks of gestation in a previously normotensive woman.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Chronic Hypertension:</strong> Defined as blood pressure of ≥ 140/90 mm Hg that was present before pregnancy or diagnosed before the 20th week of gestation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Diabetic retinopathy:</strong> This condition is a complication of diabetes affecting the eyes, not a direct indicator of systemic hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Diabetic nephropathy:</strong> This is a complication of diabetes that affects the kidneys and can be associated with hypertension, but it is not specific to the definition of systemic hypertension in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Episode of seizure:</strong> Seizures in the context of pregnancy are associated with eclampsia, a severe form of preeclampsia, but do not directly define systemic hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Systemic hypertension in pregnancy is diagnosed if high blood pressure is present before pregnancy, is diagnosed before 20 weeks of gestation, or persists beyond 12 weeks postpartum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 1778, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22692,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56953,
      "choices": [
        {
          "id": 227201,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        },
        {
          "id": 227202,
          "text": "<p><span style=\"font-size:12.0pt;\">LMWH (Low Molecular Weight Heparin)</span></p>"
        },
        {
          "id": 227203,
          "text": "<p><span style=\"font-size:12.0pt;\">Fondaparinux</span></p>"
        },
        {
          "id": 227204,
          "text": "<p><span style=\"font-size:12.0pt;\">Apixaban</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman in her second pregnancy is diagnosed with deep vein thrombosis (DVT) at 30 weeks gestation. What is the drug of choice for her treatment?&nbsp;(NEET PG 2024)</span></p>",
      "unique_key": "Q7786045",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589302,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) LMWH (Low Molecular Weight Heparin)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Low Molecular Weight Heparin (LMWH)</strong>. LMWH is the preferred treatment for deep vein thrombosis (DVT) during pregnancy due to its safety profile and ease of monitoring. LMWH does not cross the placenta, making it safer for the fetus compared to other anticoagulants. Additionally, LMWH requires less frequent monitoring compared to unfractionated heparin, making it more convenient for both patients and healthcare providers during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Warfarin</strong>: Warfarin is <strong>contraindicated in pregnancy</strong> because it crosses the placenta and can lead to fetal complications, including congenital malformations and bleeding. Warfarin is generally reserved for patients with specific conditions such as mechanical heart valves who were already on the drug before pregnancy, under careful supervision.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fondaparinux</strong>: While Fondaparinux is an anticoagulant, it is not the first-line choice for DVT in pregnancy. <strong>It is generally considered when LMWH is contraindicated</strong>, such as in cases of heparin-induced thrombocytopenia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Apixaban</strong>: Apixaban, a direct oral anticoagulant (DOAC), is not recommended in pregnancy due to insufficient safety data. DOACs are <strong>generally avoided during pregnancy</strong> because they can cross the placenta and pose risks to the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In pregnancy, the drug of choice for treating DVT is Low Molecular Weight Heparin (LMWH) due to its safety and ease of monitoring compared to other anticoagulants</span></p>",
      "correct_choice_id": 227202,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/56953/Neet_Pg_Aug_2024_Obg_Q_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/56953/Neet_Pg_Aug_2024_Obg_Q_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55342,
      "choices": [
        {
          "id": 220829,
          "text": "<p><span style=\"font-size:12.0pt;\">ITP</span></p>"
        },
        {
          "id": 220830,
          "text": "<p><span style=\"font-size:12.0pt;\">Gestational thrombocytopenia</span></p>"
        },
        {
          "id": 220831,
          "text": "<p><span style=\"font-size:12.0pt;\">HELLP syndrome</span></p>"
        },
        {
          "id": 220832,
          "text": "<p><span style=\"font-size:12.0pt;\">Malaria in pregnancy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Most common cause of thrombocytopenia in pregnancy? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q1208933",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589857,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Gestational thrombocytopenia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gestational thrombocytopenia is the most common cause of thrombocytopenia in pregnancy. It is generally a benign condition associated with mild thrombocytopenia, where platelet counts typically range between 100,000 to 150,000 per microliter. It is not linked to adverse pregnancy outcomes and usually resolves spontaneously after delivery. The exact cause is not well understood, but it is believed to be related to the normal hemodilution and increased platelet turnover during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. ITP (Idiopathic Thrombocytopenic Purpura):</strong> While ITP can cause thrombocytopenia in pregnancy, it is less common than gestational thrombocytopenia. ITP involves an autoimmune response leading to severe platelet destruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. HELLP syndrome:</strong> HELLP syndrome is a severe form of preeclampsia that includes hemolysis, elevated liver enzymes, and low platelets. While it causes thrombocytopenia, it is not as common as gestational thrombocytopenia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Malaria in pregnancy:</strong> Malaria can cause thrombocytopenia, but it is not the most common cause during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gestational thrombocytopenia is the most common cause of mild thrombocytopenia during pregnancy and is usually not associated with adverse outcomes.</span></p>",
      "correct_choice_id": 220830,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5968,
      "choices": [
        {
          "id": 23842,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan syndrome</span></span></span></p>"
        },
        {
          "id": 23843,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypothyroidism</span></span></span></p>"
        },
        {
          "id": 23844,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature ovarian failure</span></span></span></p>"
        },
        {
          "id": 23845,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delayed blood transfusion reaction</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 26-year-old female patient came with a history of fatiguability and constipation for the past 1 year. She has a history of multiple blood transfusions after delivery 4 years ago. She has had lactational failure and never regained her periods after the delivery. What is the most probable diagnosis?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>(NEET PG 2021)</p>",
      "unique_key": "Q3936607",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589309,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Sheehan syndrome </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan syndrome:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most probable diagnosis in a woman with lactational failure and postpartum amenorrhea, now presenting with fatiguability and constipation, is Sheehan syndrome.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan syndrome refers to panhypopituitarism occurring as a result of pituitary ischemia and necrosis following massive obstetrical hemorrhage.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The history of multiple blood transfusions after delivery indicates significant blood loss, which resulted in pituitary ischemia leading to this condition.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Symptoms such as fatiguability and constipation can be attributed to secondary hypothyroidism resulting from pituitary dysfunction.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hypothyroidism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> </strong>While hypothyroidism can cause fatiguability and constipation, the history of postpartum amenorrhea and lactational failure makes Sheehan syndrome more likely. In Sheehan syndrome, hypothyroidism is a secondary consequence of pituitary dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Premature ovarian failure</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> </strong>Premature ovarian failure typically presents with symptoms of estrogen deficiency such as hot flashes and vaginal dryness, along with amenorrhea. However, it does not account for the history of significant postpartum hemorrhage and lactational failure seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Delayed blood transfusion reaction</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> </strong>Delayed blood transfusion reactions usually present with symptoms such as jaundice, fever, and anemia, but they do not explain the chronic symptoms of fatiguability, constipation, lactational failure, and amenorrhea in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan syndrome is characterized by panhypopituitarism due to pituitary ischemia and necrosis following massive obstetrical hemorrhage, leading to symptoms such as lactational failure, amenorrhea, fatiguability, and constipation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 465, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23842,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47298,
      "choices": [
        {
          "id": 188803,
          "text": "<p><span style=\"font-size:12.0pt;\">Preeclampsia</span></p>"
        },
        {
          "id": 188804,
          "text": "<p><span style=\"font-size:12.0pt;\">Abruption</span></p>"
        },
        {
          "id": 188805,
          "text": "<p><span style=\"font-size:12.0pt;\">PPH</span></p>"
        },
        {
          "id": 188806,
          "text": "<p><span style=\"font-size:12.0pt;\">Gestational Hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Patient came to the emergency department with 32 weeks of pregnancy with pedal edema and BP of 140/90 mmHg. Urine dipstick was 2+. What is the likely diagnosis?&nbsp;(FMGE JULY 2023)</span></p>",
      "unique_key": "Q8274686",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589862,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Preeclampsia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with symptoms that align with the diagnosis of preeclampsia, which is characterized by the following criteria:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Elevated blood pressure (≥140/90 mmHg) <strong>after 20 weeks of gestation.</strong></span></li><li><span style=\"font-size:12.0pt;\">Proteinuria (≥1+ on dipstick or 300 mg/24 hours).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, the patient has a blood pressure of 140/90 mmHg and a urine dipstick showing 2+ proteinuria, which fits the criteria for preeclampsia. The presence of pedal edema further supports this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Abruption</strong>: This typically presents with painful vaginal bleeding and uterine tenderness. While preeclampsia can be a risk factor for abruption, the absence of vaginal bleeding in this case makes abruption less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. PPH (Postpartum Hemorrhage)</strong>: This occurs after delivery and is characterized by significant bleeding post-delivery, which is not relevant in this antepartum scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Gestational Hypertension</strong>: This is characterized by elevated blood pressure without proteinuria or other signs of preeclampsia. The presence of proteinuria in this patient rules out gestational hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Preeclampsia is diagnosed in pregnant patients presenting with hypertension and proteinuria after 20 weeks of gestation. This condition requires careful monitoring and management to prevent complications for both the mother and the fetus.</span></p>",
      "correct_choice_id": 188803,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/47298/FMGE_July_-_2023OBG_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/47298/FMGE_July_-_2023OBG_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5877,
      "choices": [
        {
          "id": 23478,
          "text": "<p><span style=\"font-size:12pt;\">4 ml Mgso4 (50% w/v) in 16 ml NS</span></p>"
        },
        {
          "id": 23479,
          "text": "<p><span style=\"font-size:12pt;\">8 ml MgSo4 (50% w/v) in 12 ml NS</span></p>"
        },
        {
          "id": 23480,
          "text": "<p><span style=\"font-size:12pt;\">12 ml MgSo4 (50% w/v) in 8 ml NS</span></p>"
        },
        {
          "id": 23481,
          "text": "<p><span style=\"font-size:12pt;\">10 ml MgSO4 (50% w/v)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The loading dose of MgSo4 in pre-eclampsia is?&nbsp;</span>(INICET NOV 2019)</p>",
      "unique_key": "Q7349135",
      "question_audio": null,
      "question_video": null,
      "map_id": 37594069,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 8 ml MgSo4 (50% w/v) in 12 ml NS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The drug of choice for the management of eclampsia is Magnesium Sulfate (MgSO4). The most commonly used regimen in India is the Pritchard regimen, which involves an initial loading dose followed by maintenance doses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For the loading dose, the Pritchard regimen recommends:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Loading dose:</strong> 4 grams of MgSO4 as a 20% solution administered intravenously at 1 gram per minute.</span></li><li><span style=\"font-size:12pt;\">Additionally, 10 grams of 50% MgSO4 is administered intramuscularly, with 5 grams in each buttock.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this question, option B, \"8 ml MgSO4 (50% w/v) in 12 ml NS,\" correctly refers to the preparation required to administer the initial dose of MgSO4.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The preparation details:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">MgSO4 is available in 50% and 20% concentrations.</span></li><li><span style=\"font-size:12pt;\">To make a 50% MgSO4 solution into a 20% solution, a 1.5 times dilution is required.</span></li><li><span style=\"font-size:12pt;\">For a 50% MgSO4 solution, 1 ml of the solution contains 0.5 grams of MgSO4 (1 ampoule = 2 ml).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The loading dose of MgSO4 in pre-eclampsia, as per the Pritchard regimen, is 4 grams of MgSO4 as a 20% solution administered intravenously, often prepared using 8 ml of 50% MgSO4 diluted in 12 ml normal saline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg273, Williams textbook of obstetrics 24<sup>th</sup> edition pg 1840</strong></span></p>",
      "correct_choice_id": 23479,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56835,
      "choices": [
        {
          "id": 226733,
          "text": "<p><span style=\"font-size:12.0pt;\">Knee jerk presen</span></p>"
        },
        {
          "id": 226734,
          "text": "<p><span style=\"font-size:12.0pt;\">RR 18/min</span></p>"
        },
        {
          "id": 226735,
          "text": "<p><span style=\"font-size:12.0pt;\">Visual disturbance</span></p>"
        },
        {
          "id": 226736,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine output 60ml in 4hr</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old woman with eclampsia is on a maintenance dose of MgSO₄. When will you stop MgSO₄? (NEET PG 2024)</span></p>",
      "unique_key": "Q2732293",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589303,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Urine output 60ml in 4hr</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Magnesium sulfate (MgSO₄) is used in eclampsia management to prevent seizures. However, MgSO₄ toxicity can occur, which necessitates stopping or adjusting the dose. The first sign of MgSO₄ toxicity is the absence of deep tendon reflexes (DTRs), followed by respiratory depression and reduced urine output. Since magnesium is excreted through the kidneys, urine output is a critical measure of magnesium toxicity risk. A urine output of <strong>less than 30 ml per hour</strong> (or 60 ml in 4 hours) indicates poor excretion and potential toxicity, requiring immediate adjustment or cessation of MgSO₄.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Knee jerk present:</strong> The presence of a knee jerk (deep tendon reflex) is a positive sign and indicates that magnesium levels are not yet toxic. The absence of DTRs is the first indication of toxicity, so this is not a reason to stop MgSO₄.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. RR 18/min:</strong> A respiratory rate above 10 breaths per minute is safe when on MgSO₄. Respiratory depression is a sign of advanced toxicity; therefore, a rate of 18 per minute is not concerning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Visual disturbances:</strong> Visual disturbances are symptoms associated with eclampsia or pre-eclampsia (e.g., retinal detachment or blurred vision) but are not signs of MgSO₄ toxicity. These do not indicate the need to stop MgSO₄.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">MgSO₄ should be stopped if the patient’s urine output is less than 30 ml per hour (or 60 ml in 4 hours), as this indicates poor excretion and risk of magnesium toxicity.</span></p>",
      "correct_choice_id": 226736,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/56835/Neet_Pg_Aug_2024_Obg_Q_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/56835/Neet_Pg_Aug_2024_Obg_Q_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5943,
      "choices": [
        {
          "id": 23742,
          "text": "<p><span style=\"font-size:12pt;\">Aspirin only</span></p>"
        },
        {
          "id": 23743,
          "text": "<p><span style=\"font-size:12pt;\">Aspirin + heparin</span></p>"
        },
        {
          "id": 23744,
          "text": "<p><span style=\"font-size:12pt;\">Aspirin + heparin + steroids</span></p>"
        },
        {
          "id": 23745,
          "text": "<p><span style=\"font-size:12pt;\">Aspirin + steroids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant lady with a history of recurrent abortions is now diagnosed to have antiphospholipid syndrome. What would be the best mode of treatment for her? (NEET PG 2019)</span></p>",
      "unique_key": "Q1383384",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589313,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Aspirin + heparin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Aspirin + heparin:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by recurrent pregnancy loss, thrombosis, and the presence of antiphospholipid antibodies.</span></li><li><span style=\"font-size:12pt;\">The primary cause of pregnancy loss in APS is believed to be due to inhibition of trophoblast function and differentiation, which leads to placental dysfunction.</span></li><li><span style=\"font-size:12pt;\">The best management approach for pregnant women with APS includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Low dose aspirin</strong>: Initiated as soon as pregnancy is confirmed. Aspirin helps by preventing platelet aggregation and improving blood flow to the placenta.</span></li><li><span style=\"font-size:12pt;\"><strong>Low Molecular Weight Heparin (LMWH)</strong>: Started once fetal cardiac activity is detected. LMWH helps prevent blood clot formation, thus reducing the risk of thrombosis and improving pregnancy outcomes.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Aspirin only:</strong> While low-dose aspirin is beneficial, it is not sufficient alone for the prevention of complications in APS. The addition of heparin provides better protection against thrombosis and pregnancy loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Aspirin + heparin +</strong> <strong>steroids</strong>:&nbsp;Steroids are not routinely used in the management of APS during pregnancy due to their potential side effects and lack of evidence showing added benefit in preventing pregnancy loss when combined with aspirin and heparin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Aspirin + steroids:&nbsp;</strong>Similar to the previous option, steroids are not recommended as part of the standard management for APS in pregnancy. The combination of aspirin and heparin is the preferred treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The best management for pregnant women with antiphospholipid syndrome (APS) to prevent recurrent pregnancy loss includes low-dose aspirin and low molecular weight heparin (LMWH).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2907, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23743,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23219,
      "choices": [
        {
          "id": 92840,
          "text": "<p><span style=\"font-size:12pt;\">HIV ELISA</span></p>"
        },
        {
          "id": 92841,
          "text": "<p><span style=\"font-size:12pt;\">VDRL</span></p>"
        },
        {
          "id": 92842,
          "text": "<p><span style=\"font-size:12pt;\">Dark ground microscopy</span></p>"
        },
        {
          "id": 92843,
          "text": "<p><span style=\"font-size:12pt;\">Culture</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant female visited the obstetrics and gynecology outpatient department (OBG OPD) for her regular prenatal examination. Her past pregnancy involved a stillbirth at 28 weeks. She has a history of engaging in sexual relations with multiple partners and recalls a painless sore on her vulva before her previous pregnancy. What initial investigative step should be taken for this patient?</span>&nbsp;(INICET MAY 2023)</p>",
      "unique_key": "Q8060003",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589762,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) VDRL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given scenario with a pregnant female has a history of stillbirth and painless genital ulcer is suggestive of Syphilis. So, Venereal disease research laboratory test (VDRL test) will be the first investigation to be done.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>SYPHILIS IN PREGNANCY</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Caused by Treponema pallidum</span></li><li><span style=\"font-size:12pt;\">Primary Syphilis – Characterized by painless, nontender, single papule over the genitalia, that rapidly becomes eroded and usually becomes indurated, and is called a hard chancre.</span></li><li><span style=\"font-size:12pt;\">Kassowitz Law – gradually improving fetal outcomes in congenital syphilis</span></li><li><span style=\"font-size:12pt;\">Screening test – VDRL (done for all antenatal patients; May be false positive)</span></li><li><span style=\"font-size:12pt;\">USG: FGR, hepatomegaly, fetal anemia, hydrops, placentomegaly</span></li><li><span style=\"font-size:12pt;\">Treatment – Benzathine penicillin 2.4 million U</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. HIV ELISA</strong>: HIV ELISA is done routinely for screening antenatal patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Dark ground microscopy</strong>: Dark ground microscopy is done when an active ulcer is present.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Culture</strong>: Treponema pallidum can’t be cultured. It is not the preferred method to diagnose or screen syphilis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For a pregnant woman with a history of stillbirth and a painless genital ulcer, the initial investigation should be the VDRL test to screen for syphilis, as syphilis can significantly impact pregnancy outcomes and requires prompt treatment.</span></p>",
      "correct_choice_id": 92841,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/23219/INICET_May_2023_OBG_Questions_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/23219/INICET_May_2023_OBG_Questions_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6007,
      "choices": [
        {
          "id": 23998,
          "text": "<p><span style=\"font-size:12pt;\">MgSO<sub>4</sub> causes uterine relaxation, but is dose dependent</span></p>"
        },
        {
          "id": 23999,
          "text": "<p><span style=\"font-size:12pt;\">MgSO<sub>4</sub> is continued upto 24 hours after delivery or last attack of seizure</span></p>"
        },
        {
          "id": 24000,
          "text": "<p><span style=\"font-size:12pt;\">It has inhibitory effect on cerebral cortex thereby preventing seizures and lowering the BP</span></p>"
        },
        {
          "id": 24001,
          "text": "<p><span style=\"font-size:12pt;\">In renal failure, MgSO4 loading dose can be given, but maintenance dose should be adjusted based on renal function</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements regarding MgSO<sub>4</sub> is false?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q5045549",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589768,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) It has inhibitory effect on cerebral cortex thereby preventing seizures and lowering the BP</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The statement that MgSO4 has an inhibitory effect on the cerebral cortex thereby preventing seizures and lowering the BP is false. MgSO4 is indeed effective in preventing seizures, particularly in the context of eclampsia, due to its action on the cerebral cortex. However, it does not lower blood pressure. Instead, its primary role is as an anticonvulsant and a tocolytic (uterine relaxant), not as an antihypertensive agent. MgSO4’s role in managing hypertension is minimal, and it is not used specifically for blood pressure control.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. MgSO4 causes uterine relaxation, but is dose dependent:</strong> This statement is true. MgSO4 is used as a tocolytic to relax the uterus in a dose-dependent manner. It helps in managing preterm labor by relaxing uterine contractions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. MgSO4 is continued up to 24 hours after delivery or the last attack of seizure:</strong> This statement is true. Magnesium sulfate is continued for 24 hours after delivery or the last seizure to prevent recurrence of seizures and to provide adequate time for stabilization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. In renal failure, MgSO4 loading dose can be given, but the maintenance dose should be adjusted based on renal function:</strong> This statement is true. In patients with renal failure, the loading dose of MgSO4 can be given, but the maintenance dose should be carefully adjusted due to impaired excretion of magnesium, which could lead to toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">MgSO4 is used for preventing seizures in eclampsia and causes uterine relaxation but does not lower blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 1867, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24000,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6007/Ini_-_Cet_May_-_2022_Obg_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6007/Ini_-_Cet_May_-_2022_Obg_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6017,
      "choices": [
        {
          "id": 24038,
          "text": "<p><span style=\"font-size:12pt;\">Growth of 10<sup>3</sup> coliform in suprapubic sample</span></p>"
        },
        {
          "id": 24039,
          "text": "<p><span style=\"font-size:12pt;\">Growth of 10<sup>5</sup> coliform in voided urine sample</span></p>"
        },
        {
          "id": 24040,
          "text": "<p><span style=\"font-size:12pt;\">Frequency with dysuria with &gt;3 WBC/HPF</span></p>"
        },
        {
          "id": 24041,
          "text": "<p><span style=\"font-size:12pt;\">Frequency with dysuria with positive nitrite and leucoesterase dipstick test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Urinary tract infection in a pregnant lady in her 2nd trimester is best defined as:&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q6065375",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589767,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Growth of 10<sup>5</sup> coliform in voided urine sample</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A urinary tract infection (UTI) in a pregnant woman is best defined by the growth of 10^5 coliforms per milliliter in a voided urine sample. This threshold is used to differentiate significant bacterial growth from contamination or a non-infectious presence of bacteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In pregnancy, the standard diagnostic method for UTI is a urine culture. A growth of 10^5 or more coliforms per milliliter in a properly collected voided urine sample is considered diagnostic for UTI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Growth of 10<sup>3 </sup>coliform in suprapubic sample:</strong> Growth of 10^3 coliforms in a suprapubic sample is <strong>not a standard criterion</strong> for diagnosing UTI. Typically, suprapubic aspiration is used for more precise diagnoses, and lower thresholds may be acceptable due to reduced contamination risk compared to voided samples. However, for voided samples, the threshold is higher.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Frequency with dysuria with &gt;3 WBC/HPF:</strong> Frequency with dysuria and &gt;3 WBC/HPF indicates inflammation and <strong>possible infection</strong> but does not define a UTI by itself. The presence of WBCs in urine is a sign of inflammation or infection but is not specific for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Frequency with dysuria with positive nitrite and leucoesterase dipstick test:</strong> Frequency with dysuria and positive nitrite and leucocyte esterase dipstick tests <strong>suggest a UTI but are not definitive</strong>. These tests are helpful as preliminary screening tools but are not as definitive as a quantitative urine culture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A urinary tract infection in a pregnant lady in her 2nd trimester is best defined as the growth of 10^5 coliforms in a voided urine sample.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 348, DC Dutta’s Textbook of Obstetrics 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24039,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6017/INI_-_CET_May_-_2022_OBG_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6017/INI_-_CET_May_-_2022_OBG_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6026,
      "choices": [
        {
          "id": 24074,
          "text": "<p><span style=\"font-size:12pt;\">Susceptible to chicken pox</span></p>"
        },
        {
          "id": 24075,
          "text": "<p><span style=\"font-size:12pt;\">Immune to chickenpox</span></p>"
        },
        {
          "id": 24076,
          "text": "<p><span style=\"font-size:12pt;\">Susceptible to zoster</span></p>"
        },
        {
          "id": 24077,
          "text": "<p><span style=\"font-size:12pt;\">Immune to zoster</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 21-year-old primigravida presents to the antenatal OPD. Her school going nephew who lives in the same house has contracted varicella. A blood sample is taken for Antibodies against varicella. The report is negative. What does this signify? (NEET PG 2021)</span></p>",
      "unique_key": "Q4940150",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589307,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Susceptible to chicken pox</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Chickenpox in Pregnancy:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Pregnant women with uncertain or no previous history of chickenpox, who have been exposed to the infection, should have a blood test to determine their immunity to Varicella-Zoster Virus (VZV).</span></li><li><span style=\"font-size:12pt;\"><strong>A negative antibody test indicates that the woman is not immune to VZV and is susceptible to chickenpox.</strong></span></li><li><span style=\"font-size:12pt;\">If a pregnant woman is not immune and has had significant exposure, she is at risk of developing chickenpox and should be administered varicella-zoster immunoglobulin (VZIG).</span></li><li><span style=\"font-size:12pt;\">VZIG is effective up to 10 days after contact.</span></li><li><span style=\"font-size:12pt;\">Symptomatic treatment of chickenpox in pregnancy includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Oral Acyclovir if within 24 hours of the onset of the rash and if the gestational age is greater than 20 weeks.</span></li><li><span style=\"font-size:12pt;\">Intravenous Acyclovir should be given to all pregnant women with severe chickenpox.</span></li></ul></li><li><span style=\"font-size:12pt;\">VZIG has no therapeutic benefit once chickenpox has started.</span></li><li><span style=\"font-size:12pt;\">Women who develop chickenpox in pregnancy should be referred to a fetal medicine specialist at 16–20 weeks or 5 weeks after infection to look for congenital varicella syndrome.</span></li><li><span style=\"font-size:12pt;\">If the infection occurs in the last 4 weeks of pregnancy, there is a risk of varicella infection in the newborn. Planned delivery should normally be avoided for at least 7 days after the onset of the maternal rash to allow for the passive transfer of antibodies from mother to child.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_IxpWkxa.png\" width=\"1053\" height=\"685\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Immune to chickenpox:&nbsp;</strong>A negative antibody test does not signify immunity; it signifies susceptibility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Susceptible to zoster:&nbsp;</strong>Varicella-zoster virus causes both chickenpox (primary infection) and shingles (reactivation). A negative test for varicella antibodies indicates susceptibility to the primary infection (chickenpox), not to shingles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Immune to zoster:&nbsp;</strong>Immunity to zoster would imply prior exposure to the varicella-zoster virus, which is not indicated by a negative varicella antibody test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A negative varicella antibody test in a pregnant woman indicates that she is susceptible to chickenpox and should receive VZIG if exposed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 3085, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24074,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6026/Neet_Pg_2021_Obg_Q_23.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/6026/Neet_Pg_2021_Obg_Q_23.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23233,
      "choices": [
        {
          "id": 92896,
          "text": "<p><span style=\"font-size:12pt;\">ABO incompatibility</span></p>"
        },
        {
          "id": 92897,
          "text": "<p><span style=\"font-size:12pt;\">Chromosome defect</span></p>"
        },
        {
          "id": 92898,
          "text": "<p><span style=\"font-size:12pt;\">Parvovirus B19</span></p>"
        },
        {
          "id": 92899,
          "text": "<p><span style=\"font-size:12pt;\">Alpha thalassemia major</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the subsequent factors can lead to non-immune hydrops except for:&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q5087126",
      "question_audio": null,
      "question_video": null,
      "map_id": 37589761,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) ABO incompatibility</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Non-immune hydrops refers to fetal hydrops that occur due to causes other than those related to maternal-fetal blood group incompatibility. ABO incompatibility is an immune-related cause of hydrops, known as immune hydrops, where the mother's immune system attacks the fetus's red blood cells due to incompatible ABO blood types. Non-immune hydrops arises from various other causes such as cardiovascular issues, genetic disorders, congenital infections, hematologic disorders, placental problems, and miscellaneous conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Chromosome defect</strong>: Chromosomal abnormalities, such as trisomy 21, 18, or 13, can cause non-immune hydrops through associated congenital abnormalities or malformations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Parvovirus B19</strong>: This is a viral infection that can cause non-immune hydrops by affecting the fetus's red blood cells, leading to severe anemia and hydrops.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Alpha thalassemia major</strong>: This is a hematologic disorder that results in severe anemia, which can lead to non-immune hydrops.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">ABO incompatibility leads to immune hydrops and is not a cause of non-immune hydrops.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-105104.png\" alt=\"\" width=\"1000\" height=\"990\"></p>",
      "correct_choice_id": 92896,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/23233/INICET_May_2023_OBG_Questions_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/23233/INICET_May_2023_OBG_Questions_14.mp4",
      "question_images": [],
      "explanation_images": []
    }
  ]
}